General Information of Drug (ID: DMRHGI9)

Drug Name
Cisplatin
Synonyms
Abiplatin; Biocisplatinum; Briplatin; Cismaplat; Cisplatine; Cisplatino; Cisplatinum; Cisplatyl; Citoplationo; Lederplatin; Neoplatin; Plastin; Platamine; Platidiam; Platinoxan; Randa; Cis-DDP; Cis-Diamminedichloroplatinum; Peyrone's chloride; Peyrone's salt; Cis-Dichlorodiammineplatinum(II); Cis-[PtCl2(NH3)2]; Cis-diamminedichloridoplatinum(II); Trans-diamminedichloridoplatinum(II); (SP-4-1)-diamminedichloridoplatinum; (SP-4-1)-diamminedichloroplatinum; (SP-4-2)-diamminedichloridoplatinum; (SP-4-2)-diamminedichloroplatinum; Cisplatin (Chemotherapy)
Indication
Disease Entry ICD 11 Status REF
Adenocarcinoma 2D40 Approved [1]
Anterior urethra cancer N.A. Approved [1]
Carcinoma 2A00-2F9Z Approved [1]
Central nervous system neoplasm N.A. Approved [1]
Epithelial ovarian cancer 2B5D Approved [1]
Epithelioid mesothelioma 2F10 Approved [1]
Esophageal squamous cell carcinoma 2E60.1 Approved [1]
Extragonadal germ cell tumor N.A. Approved [1]
Gastric intestinal type adenocarcinoma N.A. Approved [1]
Gastroesophageal junction adenocarcinoma 2B71 Approved [1]
Lung cancer 2C25.0 Approved [1]
Non-small-cell lung cancer 2C25.Y Approved [1]
Plasma cell myeloma 2A83.1 Approved [1]
Posterior urethra cancer N.A. Approved [1]
Primary peritoneal carcinoma N.A. Approved [1]
Primitive neuroectodermal tumor N.A. Approved [1]
Sarcomatoid mesothelioma N.A. Approved [1]
Small-cell lung cancer 2C25.Y Approved [1]
Solid tumour/cancer 2A00-2F9Z Approved [2]
Testicular germ cell tumor N.A. Approved [1]
Urinary bladder neoplasm N.A. Approved [1]
Osteosarcoma 2B51 Phase 2 [3]
Gastric cancer 2B72 Investigative [1]
⏷ Show the Full List of Indication(s)
Therapeutic Class
Anticancer Agents
Affected Organisms
Humans and other mammals
ATC Code
L01XA01: Cisplatin
L01XA: Platinum compounds
L01X: OTHER ANTINEOPLASTIC AGENTS
L01: ANTINEOPLASTIC AGENTS
L: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Drug Type
Small molecular drug
Structure
3D MOL is unavailable 2D MOL
#Ro5 Violations (Lipinski):
0
Molecular Weight 300.05
Logarithm of the Partition Coefficient Not Available
Rotatable Bond Count 0
Hydrogen Bond Donor Count 2
Hydrogen Bond Acceptor Count 2
ADMET Property
BDDCS Class
Biopharmaceutics Drug Disposition Classification System (BDDCS) Class 1: high solubility and high permeability [4]
Elimination
2.3% of drug is excreted from urine in the unchanged form [4]
Half-life
The concentration or amount of drug in body reduced by one-half in 30 minutes (platinum in plasma), and more than 5 days (complexes between albuminutes and the platinum) [5]
MRTD
The Maximum Recommended Therapeutic Dose (MRTD) of drug that ensured maximising efficacy and moderate side effect is 4.74882 micromolar/kg/day [6]
Water Solubility
The ability of drug to dissolve in water is measured as 2.53 mg/mL [4]
Adverse Drug Reaction (ADR)
ADR Term Variation Related DOT DOT ID REF
Cell-mediated cytotoxicity Not Available PTK6 OT7NWIQ0 [7]
Electrolyte imbalance Not Available BGLAP OTK1YLWQ [7]
Electrolyte imbalance Not Available PTH1R OTQF5ZAK [7]
Hypersensitivity Not Available YBT1 OTPQCBKA [7]
Nephropathy toxic Not Available HEXA OT48T897 [7]
Neutropenia rs4627050 PTPN5 OT2H1KDK [8]
Neutropenia rs2406342 ZNF236 OTXXMGJA [8]
Ototoxicity rs2075252 LRP2 OTZ6W681 [9]
Renal failure acute Not Available NCOA1 OTLIUJQD [7]
Renal failure acute Not Available ACOX1 OTM0A0DY [7]
Renal failure acute Not Available RXRA OTP1TBDM [7]
⏷ Show the Full List of 11 ADR Information of This Drug
Chemical Identifiers
Formula
Cl2H6N2Pt
IUPAC Name
azane;dichloroplatinum
Canonical SMILES
N.N.Cl[Pt]Cl
InChI
InChI=1S/2ClH.2H3N.Pt/h2*1H;2*1H3;/q;;;;+2/p-2
InChIKey
LXZZYRPGZAFOLE-UHFFFAOYSA-L
Cross-matching ID
PubChem CID
5702198
CAS Number
15663-27-1
UNII
Q20Q21Q62J
DrugBank ID
DB00515
TTD ID
D0U5HU
VARIDT ID
DR00291
INTEDE ID
DR0332
ACDINA ID
D00950
Combinatorial Drugs (CBD) Click to Jump to the Detailed CBD Information of This Drug
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Human Deoxyribonucleic acid (hDNA) TTUTN1I NOUNIPROTAC Modulator [10]

Drug Transporter (DTP)
DTP Name DTP ID UniProt ID MOA REF
High affinity copper uptake protein 1 (SLC31A1) DTP8L4F COPT1_HUMAN Substrate [11]
Copper-transporting ATPase 2 (ATP7B) DT206GF ATP7B_HUMAN Substrate [12]
Multidrug resistance-associated protein 6 (ABCC6) DT582KR MRP6_HUMAN Substrate [13]
Probable low affinity copper uptake protein 2 (SLC31A2) DT8Q56F COPT2_HUMAN Substrate [14]
Multidrug resistance-associated protein 2 (ABCC2) DTFI42L MRP2_HUMAN Substrate [15]
Organic cation transporter 1 (SLC22A1) DTT79CX S22A1_HUMAN Substrate [16]
Multidrug resistance-associated protein 1 (ABCC1) DTSYQGK MRP1_HUMAN Substrate [17]
Breast cancer resistance protein (ABCG2) DTI7UX6 ABCG2_HUMAN Substrate [18]
Organic cation transporter 2 (SLC22A2) DT9IDPW S22A2_HUMAN Substrate [19]
P-glycoprotein 1 (ABCB1) DTUGYRD MDR1_HUMAN Substrate [20]

Drug-Metabolizing Enzyme (DME)
DME Name DME ID UniProt ID MOA REF
Cytochrome P450 2E1 (CYP2E1) DEVDYN7 CP2E1_HUMAN Substrate [21]
Glutathione S-transferase alpha-1 (GSTA1) DE4ZHS1 GSTA1_HUMAN Substrate [22]
Quinone reductase 1 (NQO1) DENP5RY NQO1_HUMAN Substrate [23]
Glutathione S-transferase pi (GSTP1) DEK6079 GSTP1_HUMAN Substrate [24]
Metallothionein-1A (MT1A) DE5ME8A MT1A_HUMAN Substrate [25]
Myeloperoxidase (MPO) DEA3U9Y PERM_HUMAN Substrate [26]
Metallothionein-2A (MT2A) DEFKGT7 MT2_HUMAN Substrate [25]
Glutathione S-transferase mu-1 (GSTM1) DEYZEJA GSTM1_HUMAN Substrate [24]
Superoxide dismutase 1 (SOD1) DEUTDON SODC_HUMAN Substrate [23]
Glutathione S-transferase theta-1 (GSTT1) DE3PKUG GSTT1_HUMAN Substrate [24]
Glutathione S-transferase alpha-4 (GSTA4) DEH7XYP GSTA4_HUMAN Substrate [27]

Drug Off-Target (DOT)
DOT Name DOT ID UniProt ID Interaction REF
(3R)-3-hydroxyacyl-CoA dehydrogenase (HSD17B8) OTX1DWEF DHB8_HUMAN Gene/Protein Processing [28]
(Lyso)-N-acylphosphatidylethanolamine lipase (ABHD4) OTQK3M9X ABHD4_HUMAN Gene/Protein Processing [29]
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial (CYP24A1) OTG2T749 CP24A_HUMAN Gene/Protein Processing [28]
1,4-alpha-glucan-branching enzyme (GBE1) OTK2N05B GLGB_HUMAN Gene/Protein Processing [30]
1-acyl-sn-glycerol-3-phosphate acyltransferase beta (AGPAT2) OT5I4Y9K PLCB_HUMAN Gene/Protein Processing [30]
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 (ABHD5) OTY829Z3 ABHD5_HUMAN Gene/Protein Processing [31]
1-acylglycerol-3-phosphate O-acyltransferase PNPLA3 (PNPLA3) OTR4990X PLPL3_HUMAN Gene/Protein Processing [28]
1-aminocyclopropane-1-carboxylate synthase-like protein 1 (ACCS) OTHIHI9D 1A1L1_HUMAN Gene/Protein Processing [31]
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 (PLCB2) OTPAHDGO PLCB2_HUMAN Gene/Protein Processing [30]
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 (PLCB4) OTPA0QHW PLCB4_HUMAN Gene/Protein Processing [28]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Experimental Cancer Drug Sensitivity Information

Cancer Drug Sensitivity Data Curated from 53 Cell Line(s) in Bone Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
RPMI-3460/CS1 GDSC1; GDSC2 2.3241 5.5903 1.2774 14.2644
EW-22 GDSC1; GDSC2 -0.382 2.5109 -0.5312 33.459
A-673 GDSC1; GDSC2 0.112 2.7652 -0.0464 29.1509
EW-3 GDSC1; GDSC2 0.1127 5.0511 -0.7678 32.1733
ES1 GDSC1; GDSC2 0.2725 2.9919 0.078 27.8984
ES8 GDSC1; GDSC2 0.4135 2.7425 0.2852 26.3498
ES7 GDSC1; GDSC2 0.5347 2.4129 0.4715 24.9789
SK-ES-1 GDSC1; GDSC2 0.6603 3.4663 0.3765 24.895
EW-11 GDSC1; GDSC2 0.8378 4.4599 0.2331 24.8621
ES4 GDSC1; GDSC2 1.0444 3.5365 0.7746 21.4407
SK-PN-DW GDSC1; GDSC2 1.2829 4.4011 0.7309 20.7282
HuO9 GDSC1; GDSC2 1.3473 3.5951 1.0866 18.7219
TC-71 GDSC1; GDSC2 1.6895 3.7336 1.4131 15.778
CADO-ES1 GDSC1; GDSC2 1.7574 3.5729 1.5399 14.888
ES5 GDSC1 1.787 7.0303 0.0726 25.3399
EW-13 GDSC1; GDSC2 1.9561 5.9251 0.76 18.1953
EW-1 GDSC1; GDSC2 2.1172 5.6121 1.0649 16.0675
EW-7 GDSC1; GDSC2 2.1429 5.2491 1.259 14.9538
HOS GDSC1; GDSC2 2.215 4.3324 1.7418 12.1578
CHSA0108 GDSC1 2.2551 4.7941 1.1948 10.855
EW-16 GDSC1; GDSC2 2.4937 5.3293 1.5656 12.1696
NY GDSC1; GDSC2 2.6385 6.6867 1.0408 14.5699
MHH-ES-1 GDSC1; GDSC2 2.6583 4.7271 2.0112 9.2291
U2OS GDSC1; GDSC2 2.6772 5.0755 1.8633 9.9741
MG-63 GDSC1; GDSC2 2.6946 7.4594 0.7096 16.1564
CAL-72 GDSC1; GDSC2 3.2037 5.5298 2.1179 7.0399
G-292 clone A141B1 GDSC1; GDSC2 3.3895 5.6916 2.1929 6.1397
SJSA-1 GDSC1; GDSC2 3.5269 6.1515 2.0742 6.4655
H-EMC-SS GDSC1; GDSC2 3.6313 7.8397 1.3155 10.4069
EW-18 GDSC1; GDSC2 3.6403 6.3949 2.0421 6.3765
CHSA8926 GDSC1; GDSC2 3.6572 7.6996 1.4058 9.8512
SaOS-2 GDSC1; GDSC2 3.7093 7.7142 1.4397 9.542
ES6 GDSC1; GDSC2 3.8572 7.0429 1.8865 6.7464
NOS-1 [Human HNSCC] GDSC1; GDSC2 4.0166 5.8198 2.5937 2.595
HuO-3N1 GDSC1; GDSC2 4.1431 8.3108 1.4744 8.3729
EW-24 GDSC1; GDSC2 4.284 7.8146 1.818 6.2281
CAL-78 GDSC1; GDSC2 4.4189 9.0351 1.3199 8.6186
CHSA0011 GDSC1 5.91 13.1116 0.3795 11.8262
SK-ES-1 CTRP2 6.8962 8.2944 5.5249 0.9873
Hs 822.T CTRP2 6.9311 14.2908 2.6349 12.5158
A-673 CTRP2 7.003 8.9667 5.2838 1.7521
CAL-78 CTRP2 7.4001 11.7074 4.2475 5.2992
TC71 CTRP2 7.4111 8.5767 5.6569 0.259
SK-N-MC CTRP2 7.5989 8.7454 5.6696 0.1724
U2OS CTRP2 7.6268 9.9167 5.2136 1.3755
MG-63 CTRP2 7.9864 9.9019 5.3944 0.5945
SW1353 CTRP2 8.3015 9.8004 5.5592 0.1632
MHH-ES-1 CTRP2 8.3551 10.0612 5.4867 0.2573
SaOS-2 CTRP2 8.4011 10.5363 5.3288 0.5488
Hs 888.T CTRP2 8.4196 21.5479 0.1721 18.3486
HOS CTRP2 8.4782 9.7885 5.626 0.0665
G-292 clone A141B1 CTRP2 8.7582 14.4558 3.8276 5.1804
SJSA-1 CTRP2 10.5625 26.0102 -0.4701 16.9676
⏷ Show the Full List of 53 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 313 Cell Line(s) in Haematopoietic And Lymphoid Tissue Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
MEC1 CTRP2 7.4102 9.2839 5.3714 1.0434
JK1 CTRP2 7.4355 9.5449 4.34 0.5454
JM1 GDSC1 1.9877 3.4551 1.8274 14.5753
JM1 CTRP2 7.0941 10.5168 4.611 4.2748
SCC-3 GDSC2 -1.7652 -0.3656 -1.7666 41.2401
Namalwa GDSC1; GDSC2 -0.1738 1.6444 -0.1977 31.0776
MV4-11 GDSC1; GDSC2 -0.0677 2.2589 -0.1506 30.4007
697 GDSC1; GDSC2 -0.0519 1.3992 -0.0599 29.927
Hs 445 GDSC1; GDSC2 0.2365 2.5462 0.0325 23.2699
SUP-M2 GDSC1; GDSC2 0.4444 1.8038 0.4327 25.5464
HEL GDSC1 0.522 1.8646 0.5097 28.819
L-540 GDSC1; GDSC2 0.6304 2.4312 0.5712 24.1133
NALM-6 GDSC1; GDSC2 0.7362 2.3556 0.6933 23.1015
SR GDSC1; GDSC2 0.8565 2.3531 0.821 22.0023
NKM-1 GDSC1; GDSC2 0.8965 3.7622 0.5428 23.1486
MOLM-13 GDSC1; GDSC2 0.9152 2.9725 0.6439 17.2051
RPMI-8402 GDSC1; GDSC2 1.0496 3.0213 0.9172 20.7402
BV-173 GDSC1; GDSC2 1.0684 2.9079 0.962 20.4519
LC4-1 GDSC1; GDSC2 1.083 3.1548 0.9221 20.5792
HAL-01 GDSC1; GDSC2 1.1022 3.5333 0.8386 20.9004
KE-37 GDSC1; GDSC2 1.1146 2.7464 1.0422 19.885
Karpas-231 GDSC1; GDSC2 1.1217 2.5703 1.0764 19.6977
RS4;11 GDSC1; GDSC2 1.1532 3.4444 0.9205 20.3013
ML-2 GDSC1; GDSC2 1.1845 2.9804 1.0729 19.4486
KOPN-8 GDSC1; GDSC2 1.2377 3.2474 1.0672 19.2557
SUP-B15 GDSC1; GDSC2 1.2799 3.2017 1.1251 18.8077
RCH-ACV GDSC1 1.2898 3.2774 1.1162 21.8024
P12-Ichikawa GDSC1; GDSC2 1.3005 3.0455 1.1848 18.4405
CRO-AP2 GDSC1 1.3682 4.3368 0.8468 22.9558
NB4 GDSC1 1.3846 2.6124 1.3507 20.0732
NU-DUL-1 GDSC1 1.3984 3.1164 1.275 20.4133
WIL2 NS GDSC1; GDSC2 1.3992 3.3679 1.2108 17.913
SU-DHL-8 GDSC1; GDSC2 1.541 3.2288 1.2225 11.5599
P30/OHK GDSC1; GDSC2 1.5796 2.852 1.5251 15.6841
HC-1 GDSC1; GDSC2 1.6055 3.7256 1.3248 16.5405
Jurkat GDSC1; GDSC2 1.6199 3.3004 1.4703 15.7744
BL-41 GDSC1; GDSC2 1.6235 2.4073 1.6174 15.0749
SU-DHL-5 GDSC1; GDSC2 1.6345 3.1484 1.5247 15.4563
JVM-3 GDSC1; GDSC2 1.652 4.5333 1.0691 17.6546
A3/Kawakami GDSC1; GDSC2 1.6548 1.9784 1.6548 14.7705
EoL-1 GDSC1; GDSC2 1.6763 2.7177 1.6477 14.7084
VL51 GDSC1; GDSC2 1.7119 4.2794 1.2348 16.5896
JURL-MK1 GDSC1; GDSC2 1.7185 5.3824 0.7715 18.9443
SKM-1 GDSC1 1.7266 6.5736 0.2304 24.7873
OCI-Ly19 GDSC1 1.7364 4.5109 1.1669 19.5147
H9 GDSC1; GDSC2 1.7649 4.3379 1.2675 16.2279
NOMO-1 GDSC1; GDSC2 1.809 3.8374 1.5061 14.8553
CML-T1 GDSC1; GDSC2 1.8399 3.1026 1.7587 13.5028
MOLM-16 GDSC1 1.8939 4.0845 1.2029 12.167
HL-60 GDSC1; GDSC2 1.9268 3.5208 1.7408 13.2373
P32/ISH GDSC1; GDSC2 1.9877 3.4433 1.8309 12.5565
Granta-519 GDSC1; GDSC2 2.0079 3.9725 1.6695 13.2822
DoHH2 GDSC1 2.0091 4.026 1.6501 18.8639
A4/Fukuda GDSC1; GDSC2 2.0962 4.4492 1.5686 13.4811
MOLT-4 GDSC1; GDSC2 2.1269 4.9356 1.386 14.3348
Reh GDSC1; GDSC2 2.1295 3.4748 1.9759 11.2876
OCI-AML-2 GDSC1; GDSC2 2.1377 4.528 1.5776 13.2881
SUP-HD1 GDSC1; GDSC2 2.1512 5.2227 1.2795 14.8176
GR-ST GDSC1; GDSC2 2.1605 6.7527 0.5632 18.5408
MOLT-16 GDSC1; GDSC2 2.1788 3.263 2.09 10.5392
AMO1 GDSC1; GDSC2 2.1829 4.3726 1.6913 12.5347
RPMI-6666 GDSC1; GDSC2 2.2354 5.1554 1.3944 13.9265
DEL GDSC1; GDSC2 2.2513 4.0166 1.9109 11.1524
KCL-22 GDSC1; GDSC2 2.2547 5.7743 1.1227 15.3144
OCI-AML-5 GDSC1; GDSC2 2.2576 4.7619 1.5965 12.7759
L-428 GDSC1; GDSC2 2.2985 4.8981 1.5758 12.7485
CTV-1 GDSC1; GDSC2 2.3701 5.5081 1.361 13.6679
CTB-1 GDSC1 2.3897 5.5111 1.3785 15.6424
RPMI-8866 GDSC1; GDSC2 2.401 3.8856 2.1218 9.5228
MOLP-8 GDSC1; GDSC2 2.4865 4.7888 1.4 7.3612
MHH-CALL-2 GDSC1; GDSC2 2.5061 5.9888 1.2597 13.7892
GDM-1 GDSC1; GDSC2 2.5607 5.69 1.456 12.5561
LAMA-84 GDSC1; GDSC2 2.6103 5.1103 1.7825 10.6239
QIMR-WIL GDSC1 2.6252 3.6984 2.4337 8.2346
ALL-SIL GDSC1; GDSC2 2.6294 4.4195 2.1261 8.7044
DB GDSC1; GDSC2 2.6624 8.0092 0.4083 17.7914
ATN-1 GDSC1; GDSC2 2.7914 4.9372 2.0386 8.6626
CMK GDSC1 2.7969 3.7074 2.6117 6.4485
EHEB GDSC1 2.8176 5.6683 1.2327 8.7454
Loucy GDSC1; GDSC2 2.8178 6.0038 1.5408 11.3231
KG-1 GDSC1; GDSC2 2.8332 6.9652 1.0786 13.8003
ARH-77 GDSC1; GDSC2 2.9455 4.5259 2.3832 6.3009
OCI-AML-3 GDSC1; GDSC2 2.9926 6.7333 1.3346 11.9603
Karpas-299 GDSC1; GDSC2 3.0121 5.1197 2.1534 7.373
KMS-28BM CTRP2 3.03 5.3579 2.753 15.431
U-698-M GDSC1; GDSC2 3.0803 6.0878 1.7328 9.5194
OCI-M1 GDSC1; GDSC2 3.1165 4.9304 2.3407 6.0362
ROS-50 GDSC1 3.1207 5.1044 1.739 4.4119
Daudi GDSC1; GDSC2 3.1567 6.901 1.3929 11.1925
EB2 GDSC1; GDSC2 3.1804 4.3432 2.689 3.9189
BALL-1 GDSC1; GDSC2 3.1927 5.79 1.9786 7.8464
CCRF-CEM GDSC1; GDSC2 3.2092 5.9066 1.9345 8.0489
JSC-1 GDSC1; GDSC2 3.2447 6.5939 1.6211 9.6989
MM1.S GDSC1; GDSC2 3.2563 5.2828 2.2863 5.9596
ALL-PO GDSC1; GDSC2 3.2695 7.8378 1.0202 12.9191
WSU-NHL GDSC1; GDSC2 3.2744 6.0428 1.9217 7.9485
Mono-Mac-6 GDSC1; GDSC2 3.324 6.9798 1.4947 10.1924
L-363 GDSC1; GDSC2 3.331 7.8248 1.078 12.4479
SU-DHL-10 GDSC1; GDSC2 3.3618 9.2528 -0.1258 13.8303
Ku812 GDSC1; GDSC2 3.3817 5.0257 2.5194 4.3352
Ramos.2G6.4C10 GDSC1; GDSC2 3.4028 4.938 2.5803 3.9427
HH [Human lymphoma] GDSC1; GDSC2 3.4083 5.0742 2.5167 4.2846
SUP-T1 GDSC1; GDSC2 3.4209 6.1351 1.9969 7.1555
THP-1 GDSC1 3.4446 4.8423 2.6614 3.9285
CESS GDSC1; GDSC2 3.5249 6.9392 1.6795 8.6646
KY821 GDSC1; GDSC2 3.5407 5.7417 2.2892 5.2353
KMS-12-BM GDSC1; GDSC2 3.5477 5.8289 2.2513 5.4299
KMOE-2 GDSC1; GDSC2 3.555 5.601 2.3704 4.7502
TK [Human B-cell lymphoma] GDSC1; GDSC2 3.592 5.2088 2.593 3.4317
DND-41 GDSC1; GDSC2 3.6193 6.0583 2.193 5.5871
Karpas-1106P GDSC1; GDSC2 3.6277 6.2717 2.0935 6.1205
VAL GDSC1; GDSC2 3.6296 6.9838 1.7406 8.0741
IM-9 GDSC1; GDSC2 3.6382 9.0537 0.7152 13.5833
GA-10 GDSC1; GDSC2 3.6687 6.9566 1.7849 7.7364
NCI-H929 GDSC1; GDSC2 3.6968 6.8967 1.8365 7.3853
KMS-11 GDSC1 3.7073 7.9393 1.3261 11.7276
PF-382 GDSC1; GDSC2 3.7876 5.9732 2.3615 4.2847
JVM-2 CTRP2 3.8086 6.1055 3.5875 15.6706
EM-2 GDSC1; GDSC2 3.8101 6.1434 2.2944 4.6053
SU-DHL-6 GDSC1; GDSC2 3.8303 5.9669 2.3954 4.0108
MEG-01 GDSC1; GDSC2 3.8386 7.1604 1.8144 7.1848
JeKo-1 GDSC1 3.8812 5.7607 2.5313 3.6787
MHH-PREB-1 GDSC1; GDSC2 3.8953 6.1547 2.3503 4.1242
OCI-Ly7 GDSC1 3.9226 5.3906 2.7351 2.3428
Raji GDSC1; GDSC2 3.9367 7.341 1.7989 7.0534
ST486 GDSC1; GDSC2 3.9384 6.4769 2.224 4.724
BE-13 GDSC1; GDSC2 3.9676 6.3905 2.2867 4.3244
HT GDSC1 3.9828 5.6139 2.6687 2.6227
JVM-2 GDSC1; GDSC2 4.0248 8.6008 1.2429 9.8794
SUP-T11 CTRP2 4.0282 7.0712 3.0961 11.1283
L-1236 GDSC1; GDSC2 4.0353 7.4169 1.8342 6.6489
MC116 GDSC1 4.0675 5.5837 2.7354 2.0712
YT GDSC1; GDSC2 4.0856 7.2189 1.9674 5.8191
MN-60 GDSC1; GDSC2 4.101 6.3887 2.3791 3.5739
HDLM-2 GDSC1; GDSC2 4.1315 7.7699 1.7312 7.0072
SK-MM-2 GDSC1; GDSC2 4.1337 6.4041 2.3935 3.4385
RPMI-8226 GDSC1; GDSC2 4.1338 8.0122 1.6142 7.6367
MY-M12 GDSC1 4.2254 5.9665 2.6552 2.7477
P31/FUJ GDSC1; GDSC2 4.2325 6.5506 2.3887 3.2899
Farage GDSC1 4.2682 5.634 2.8267 1.2602
U266B1 GDSC1; GDSC2 4.3044 7.767 1.8553 5.9878
MLMA GDSC1; GDSC2 4.3063 9.8601 0.8325 11.4102
OPM-2 GDSC1; GDSC2 4.3767 6.7901 2.3682 3.1538
Karpas-45 GDSC1; GDSC2 4.3866 6.0624 2.7042 1.4949
Karpas-422 GDSC1; GDSC2 4.3936 9.306 1.1692 9.4679
RC-K8 GDSC1; GDSC2 4.3948 7.6017 1.9966 5.0623
K-562 GDSC1; GDSC2 4.3972 7.2818 2.1504 4.2471
CA46 GDSC1; GDSC2 4.45 6.456 2.5652 2.0638
LP-1 GDSC1 4.5421 6.0369 2.796 1.0754
MOLT-13 GDSC1; GDSC2 4.6067 7.7489 2.0656 4.3265
KM-H2 GDSC1; GDSC2 4.6548 9.9308 1.0516 9.5403
Kasumi-1 GDSC1 4.6617 9.8482 1.0967 10.6662
JJN-3 GDSC1; GDSC2 4.6721 7.089 2.4091 2.5044
Jiyoye GDSC1; GDSC2 4.6761 9.1536 1.4429 7.4581
BC-1 GDSC1; GDSC2 4.7041 9.0942 1.4907 7.1542
DG-75 GDSC1; GDSC2 4.7305 7.8102 2.1148 3.8721
DoHH2 CTRP2 4.7731 7.5416 4.0831 11.0787
EJM GDSC1; GDSC2 4.7895 7.0782 2.4798 2.0178
SUP-B8 GDSC1 4.8128 6.7493 2.6334 1.5303
Sc-1 GDSC1 4.8171 6.3138 2.8129 0.7387
WSU-DLCL2 GDSC1; GDSC2 4.8213 8.5175 1.8421 5.1148
SU-DHL-16 GDSC1 4.8502 9.3361 1.4733 8.0374
RL GDSC1 4.8781 9.5143 1.407 8.368
ME1 GDSC1; GDSC2 4.912 8.2311 2.0319 4.004
SU-DHL-4 GDSC1 5.042 6.3554 2.891 0.3361
TUR GDSC1; GDSC2 5.0593 7.3248 2.5158 1.5538
KMS-18 CTRP2 5.3105 6.8629 4.3463 2.6345
Karpas-620 GDSC1; GDSC2 5.344 7.0052 2.7722 0.4466
GA-10 CTRP2 5.4572 7.3295 4.8648 6.2214
KMS-26 CTRP2 5.7383 6.7511 5.4121 3.3143
PL-21 GDSC1 5.9042 8.0664 2.6048 0.7073
MC116 CTRP2 5.9507 14.6713 0.9638 15.9327
MV4-11 CTRP2 5.9682 10.5045 3.7505 9.7802
NCI-H929 CTRP2 6.0197 8.3206 4.8856 4.9186
Ri-1 CTRP2 6.0328 10.2867 3.1944 6.4902
AMO1 CTRP2 6.2172 14.8837 1.0647 15.0453
EoL-1 CTRP2 6.2202 9.7829 4.3196 6.9168
REC-1 CTRP2 6.2471 9.8035 3.5771 4.4942
SU-DHL-10 CTRP2 6.2799 8.2352 4.3229 1.4149
RCH-ACV CTRP2 6.3446 9.2671 3.8932 3.0317
SUP-T1 CTRP2 6.3713 9.3671 4.647 5.2723
MOLM-16 CTRP2 6.373 9.0345 4.0177 2.4911
SU-DHL-6 CTRP2 6.3805 10.2894 3.4344 4.9061
NU-DUL-1 CTRP2 6.4153 10.3872 3.411 4.9544
SK-MM-2 CTRP2 6.4331 10.2948 4.2337 6.8912
ST486 CTRP2 6.4992 9.2569 4.7997 4.417
NCO2 CTRP2 6.5284 8.412 5.2357 2.5711
SU-DHL-8 CTRP2 6.5323 12.3992 2.5211 8.5733
MOLT-13 CTRP2 6.5388 8.8135 5.0471 3.3285
SU-DHL-1 CTRP2 6.5495 7.7658 5.5594 1.2448
MHH-CALL-4 CTRP2 6.5614 11.3714 3.0384 6.3234
MOLM-6 CTRP2 6.5625 8.7079 4.2696 1.3356
ALL-SIL CTRP2 6.5963 8.5704 5.2066 2.5883
MOLT-16 CTRP2 6.597 8.535 4.3602 0.9993
NU-DHL-1 CTRP2 6.5995 14.7267 2.1567 14.9371
HuNS1 CTRP2 6.5996 8.5335 5.2267 2.5019
SU-DHL-4 CTRP2 6.64 13.1952 2.2101 9.7048
WSU-DLCL2 CTRP2 6.6444 8.7835 5.1369 2.8004
SIG-M5 CTRP2 6.6747 8.2491 5.4127 1.6566
BCP-1 CTRP2 6.6753 9.5544 4.7834 4.1998
Karpas-620 CTRP2 6.7064 8.9894 5.0804 2.9383
697 CTRP2 6.7144 8.3194 5.405 1.6359
Peer CTRP2 6.7416 8.2825 5.4392 1.4711
Pfeiffer CTRP2 6.7441 9.1962 5.0066 3.1824
KYO-1 CTRP2 6.7513 8.6388 4.392 0.7877
KMS-12-BM CTRP2 6.7621 10.5641 3.5508 3.8922
NB4 CTRP2 6.7633 9.0425 5.0939 2.8021
Mino CTRP2 6.7701 9.4217 4.9156 3.5136
PF-382 CTRP2 6.7719 9.2505 4.9997 3.1698
MOLP-8 CTRP2 6.8047 8.5072 5.3742 1.6432
KMS-34 CTRP2 6.82 9.3527 4.1281 1.5974
Mono-Mac-1 CTRP2 6.8231 10.0939 3.8027 2.8099
MOLM-13 CTRP2 6.8601 8.5255 5.3998 1.4811
HPB-ALL CTRP2 6.8688 8.9887 4.3055 0.9679
KMS-11 CTRP2 6.9198 11.8663 3.8269 7.7486
MM1.S CTRP2 6.9353 10.4896 4.5134 4.9052
OPM-2 CTRP2 6.9598 9.2381 5.1308 2.391
RS4;11 CTRP2 6.9614 13.3943 3.1029 10.6192
SEM CTRP2 6.9624 8.5325 5.4564 1.1633
SKM-1 CTRP2 7.0288 8.2786 5.6018 0.6183
A4/Fukuda CTRP2 7.0319 9.4504 5.0772 2.5078
JVM-3 CTRP2 7.0521 8.6218 5.467 1.0392
Granta-519 CTRP2 7.1065 9.3505 5.1703 2.0593
OCI-AML-2 CTRP2 7.1231 8.88 5.3926 1.229
M-07e CTRP2 7.1492 8.8997 5.3984 1.1838
MOLT-3 CTRP2 7.2009 8.4575 5.6113 0.4736
HDLM-2 CTRP2 7.2172 10.483 4.7099 3.7081
EJM CTRP2 7.2357 9.216 5.3069 1.4193
TALL-1 [Human adult T-ALL] CTRP2 7.2419 13.7301 2.3682 8.1063
Karpas-299 CTRP2 7.2571 12.0575 3.9787 6.5943
Toledo CTRP2 7.2613 12.9995 3.5215 8.4397
RPMI-8226 CTRP2 7.2757 9.7749 5.078 2.2107
U266B1 CTRP2 7.2831 10.1416 4.9131 2.8286
Ci-1 CTRP2 7.313 8.0653 5.8029 0.0554
CA46 CTRP2 7.3166 12.6426 3.736 7.4862
Hs 611.T CTRP2 7.3372 12.0629 4.0326 6.2555
OCI-M1 CTRP2 7.3423 9.7321 5.1369 1.9191
L-428 CTRP2 7.3647 10.288 4.896 2.7948
U-937 CTRP2 7.3713 10.0128 5.0267 2.2937
Raji CTRP2 7.3827 9.1688 5.4062 0.9545
EB1 CTRP2 7.384 9.3013 5.3503 1.1342
BV-173 CTRP2 7.4508 12.3599 3.968 6.3483
OCI-AML-5 CTRP2 7.4543 17.5249 1.4326 15.9909
SUP-HD1 CTRP2 7.4852 9.8043 5.186 1.5992
OCI-Ly3 CTRP2 7.4922 9.0518 5.5076 0.5783
SUP-M2 CTRP2 7.5034 8.778 5.6193 0.3005
SUP-B15 CTRP2 7.5043 9.054 5.5123 0.5585
L-540 CTRP2 7.5087 9.1066 4.5281 0.1723
OCI-AML-3 CTRP2 7.5217 8.94 5.565 0.4154
DND-41 CTRP2 7.5506 13.2124 3.6248 7.5768
Kasumi-1 CTRP2 7.5733 11.2185 4.5935 3.7015
KMS-21-BM CTRP2 7.5876 9.4152 5.4052 0.8053
A3/Kawakami CTRP2 7.6161 8.4549 5.7767 0.0411
LP-1 CTRP2 7.6187 11.5348 4.4741 4.1073
Kasumi-2 CTRP2 7.6488 12.6849 3.9473 6.1458
Ki-JK CTRP2 7.6616 9.9136 5.2333 1.2814
HD-MY-Z CTRP2 7.665 9.0784 5.5731 0.3319
AML-193 CTRP2 7.6694 8.7821 5.6833 0.1336
Reh CTRP2 7.6798 13.9834 3.3415 8.5089
KMS-20 CTRP2 7.6802 12.409 4.1004 5.4947
EHEB CTRP2 7.6807 10.4966 4.9888 2.1005
ME1 CTRP2 7.6959 10.5374 4.9792 2.119
DEL CTRP2 7.6993 8.9253 5.6435 0.1867
BL-70 CTRP2 7.715 8.7095 5.7251 0.0743
KMS-27 CTRP2 7.7676 8.9188 5.6715 0.1278
NOMO-1 CTRP2 7.7676 10.1059 5.2063 1.281
Karpas-422 CTRP2 7.7819 9.1409 5.5973 0.2411
Jurkat CTRP2 7.7956 9.0189 5.6466 0.1564
TF-1 CTRP2 7.8094 9.6429 5.4171 0.633
JeKo-1 CTRP2 7.8188 10.2921 5.1534 1.4093
HL-60 CTRP2 7.8274 9.1231 5.6215 0.1866
MOTN-1 CTRP2 7.8741 9.9745 5.3138 0.8761
EM-2 CTRP2 7.8787 9.342 5.5619 0.2738
P31/FUJ CTRP2 7.9027 9.2891 5.5906 0.2155
KE-37 CTRP2 7.9158 9.1288 5.6525 0.1219
CMK CTRP2 7.9299 9.1258 5.6587 0.1118
KO52 CTRP2 7.9408 9.2594 5.6158 0.1661
JJN-3 CTRP2 7.962 19.0537 1.0605 16.3705
SET-2 CTRP2 7.9978 9.2535 5.639 0.1228
RPMI-8402 CTRP2 8.0161 9.4762 5.5669 0.2222
DB CTRP2 8.0191 9.8798 5.4173 0.5229
Namalwa CTRP2 8.022 10.0321 5.3591 0.664
KE-97 CTRP2 8.0266 9.3964 5.5994 0.1693
P12-Ichikawa CTRP2 8.0291 9.2338 5.6571 0.0966
RL CTRP2 8.0292 9.2947 5.6361 0.1204
SR CTRP2 8.031 9.8847 5.4205 0.5096
PL21 CTRP2 8.0347 9.247 5.6545 0.0984
MJ CTRP2 8.0743 12.3851 4.3636 3.972
Daudi CTRP2 8.0749 9.6086 5.5418 0.2469
HEL 92.1.7 CTRP2 8.0799 9.2093 5.6833 0.0646
RPMI-6666 CTRP2 8.0809 9.5126 5.5786 0.1866
GDM-1 CTRP2 8.1211 10.847 5.0733 1.4204
LAMA-84 CTRP2 8.1388 9.7211 5.5258 0.2549
K-562 CTRP2 8.1581 14.4946 3.4245 7.488
HEL CTRP2 8.1644 9.5335 5.6022 0.136
L-363 CTRP2 8.1755 18.9537 1.2682 15.3406
MHH-CALL-3 CTRP2 8.1846 16.381 2.5329 10.8566
HT CTRP2 8.2478 9.3378 5.6976 0.0387
Ku812 CTRP2 8.2773 10.0626 5.4556 0.336
OCI-Ly19 CTRP2 8.2873 10.015 5.477 0.2939
KMM-1 CTRP2 8.3202 11.3055 4.981 1.5539
CML-T1 CTRP2 8.3292 9.6969 5.6051 0.1043
P3HR-1 CTRP2 8.3789 16.5845 1.7602 8.8937
THP-1 CTRP2 8.409 9.9798 5.5359 0.1712
JURL-MK1 CTRP2 8.4259 9.8903 5.5731 0.1229
KHM-1B CTRP2 8.4501 9.8841 5.5839 0.1076
NALM-6 CTRP2 8.4784 10.0142 5.5492 0.141
OCI-Ly10 CTRP2 8.5113 10.7798 5.2825 0.6034
KCL-22 CTRP2 8.5432 10.1663 5.5199 0.1644
F-36P CTRP2 8.6172 15.5168 3.2425 7.5616
HuT 78 CTRP2 8.7244 20.1563 1.0781 15.0982
KM-H2 CTRP2 8.7632 10.1706 5.5958 0.0608
MOLP-2 CTRP2 11.3151 24.0193 0.9779 11.8754
⏷ Show the Full List of 313 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 48 Cell Line(s) in Oesophagus Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
TE15 CTRP2 8.4033 10.3304 5.4072 0.3839
TE8 CTRP2 9.2902 25.2196 -0.991 20.122
KYSE-140 GDSC1; GDSC2 1.337 4.0866 0.9076 19.6443
KYSE-510 GDSC1 1.8764 3.7149 1.6219 16.2513
KYSE-180 GDSC1; GDSC2 2.6298 4.7957 1.951 9.6468
KYSE-270 GDSC1; GDSC2 2.7836 4.5299 2.2264 7.662
TE-8 GDSC1; GDSC2 3.028 4.9161 2.2683 6.69
OE33 GDSC1; GDSC2 3.0993 5.3822 2.1009 7.419
TE-5 GDSC1; GDSC2 3.1971 4.9224 2.4154 5.3971
EC-GI-10 GDSC1; GDSC2 3.23 5.2184 2.2961 5.9748
TE-9 GDSC1; GDSC2 3.439 5.1134 2.5218 4.1813
TE-11 GDSC1 3.5188 5.9819 2.1522 7.0122
OE21 GDSC1; GDSC2 3.524 5.9776 2.1585 6.0029
KYSE-520 GDSC1; GDSC2 3.562 5.3789 2.486 4.0915
COLO 680N GDSC1; GDSC2 3.6126 5.9463 2.2434 5.3225
TE-4 GDSC1; GDSC2 3.6141 5.818 2.3082 4.9598
KYSE-70 GDSC1; GDSC2 3.6194 5.2394 2.5984 3.3419
TE-6 GDSC1; GDSC2 3.6489 5.2244 2.6275 3.1187
TE-15 GDSC1; GDSC2 3.6506 6.5084 1.9936 6.6216
KYSE-450 GDSC1; GDSC2 3.7499 5.7097 2.4632 3.8071
T.T GDSC1; GDSC2 3.7924 6.5571 2.0777 5.8359
TE-10 GDSC1 4.2178 6.5426 2.383 3.8774
KYSE-410 GDSC1; GDSC2 4.2544 6.5359 2.4097 3.1435
TE-1 GDSC1; GDSC2 4.4278 7.9455 1.8542 5.7565
KYSE-150 GDSC1; GDSC2 5.1307 9.8991 1.391 6.892
OE19 GDSC1; GDSC2 6.6554 13.6924 0.5812 8.2877
KYSE-410 CTRP2 7.5985 10.0457 5.1423 1.6423
TE-5 CTRP2 7.7057 9.4097 5.4626 0.5735
TE-9 CTRP2 7.7177 9.0902 5.5903 0.2763
KYSE-70 CTRP2 7.9658 9.8484 5.4062 0.576
KYSE-150 CTRP2 8.1021 9.2825 5.6662 0.0769
COLO 680N CTRP2 8.1256 10.0184 5.4097 0.4908
TE-11 CTRP2 8.2038 10.2106 5.3694 0.5467
KYSE-180 CTRP2 8.2577 11.381 4.9167 1.811
KYSE-510 CTRP2 8.2744 9.9566 5.4932 0.2698
OE33 CTRP2 8.2793 10.1263 5.4328 0.3792
KYSE-450 CTRP2 8.3177 9.6925 5.6025 0.1087
EC-GI-10 CTRP2 8.3235 10.2524 5.4038 0.4205
KYSE-30 CTRP2 8.3459 9.4884 5.6809 0.0412
OE19 CTRP2 8.3493 9.3673 5.7216 0.0213
OE21 CTRP2 8.3982 9.9992 5.5251 0.1882
KYSE-520 CTRP2 8.4694 10.3798 5.4154 0.3456
TE-10 CTRP2 8.524 10.2821 5.4719 0.2352
TE-1 CTRP2 8.7294 10.3662 5.518 0.1332
KYSE-140 CTRP2 8.9585 10.8883 5.4198 0.2083
TE-4 CTRP2 10.8466 28.7271 -1.5869 19.3548
TE-6 CTRP2 12.141 38.8461 -5.5948 25.2024
TE-14 CTRP2 13.3353 29.4972 -0.3062 13.1594
⏷ Show the Full List of 48 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 68 Cell Line(s) in Pancreas Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
N2a-PK1 CTRP2 8.2051 9.8569 5.5024 0.2751
PSN1 GDSC1; GDSC2 1.0032 3.5401 0.7286 21.8278
MIA PaCa-2 GDSC1; GDSC2 2.1944 6.1428 0.8888 16.7456
HuP-T4 GDSC1; GDSC2 2.5473 5.0049 1.7717 10.8821
SUIT-2 GDSC1; GDSC2 2.7337 6.0074 1.4622 12.0012
Panc 10.05 GDSC1; GDSC2 3.1318 5.991 1.8259 8.8616
BxPC-3 GDSC1; GDSC2 3.156 5.3004 2.1912 6.7595
HPAC GDSC1; GDSC2 3.3008 5.0537 2.4384 4.9936
SU.86.86 GDSC1; GDSC2 3.3445 4.4369 2.7831 2.9548
KP-4 GDSC1; GDSC2 3.4139 5.2451 2.4359 4.7218
KP-3 GDSC1; GDSC2 3.459 5.1882 2.5004 4.2526
AsPC-1 GDSC1; GDSC2 3.5118 5.8522 2.2113 5.7376
SW1990 GDSC1; GDSC2 3.577 7.6934 1.3449 10.3788
KP-1N GDSC1; GDSC2 3.5913 6.393 2.0047 6.6986
Capan-1 GDSC1; GDSC2 3.6248 7.5673 1.446 9.7095
MZ-PC-1 GDSC1; GDSC2 3.651 5.6965 2.3965 4.6119
Panc 03.27 GDSC1; GDSC2 3.7486 6.6502 1.9986 6.37
Panc 02.03 GDSC1; GDSC2 3.8251 5.8246 2.4611 3.6637
DAN-G GDSC1; GDSC2 3.864 5.7746 2.5127 3.3071
HuP-T3 GDSC1; GDSC2 3.9562 6.1001 2.4193 3.6309
Panc 08.13 GDSC1; GDSC2 3.9601 6.148 2.3989 3.7333
Hs 766T GDSC1; GDSC2 4.0428 6.5763 2.2493 4.3787
PL4 GDSC1; GDSC2 4.0847 6.9801 2.083 5.1945
CFPAC-1 GDSC1; GDSC2 4.1522 8.0035 1.6319 7.5022
KP-2 GDSC1; GDSC2 4.209 5.4043 2.8941 0.8617
PaTu 8902 GDSC1; GDSC2 4.3115 8.6379 1.4367 8.2194
PaTu 8988t GDSC1; GDSC2 4.618 6.1437 2.7889 0.8849
Capan-2 GDSC1; GDSC2 4.6762 6.8013 2.5391 1.8885
Panc 04.03 GDSC1; GDSC2 4.8508 7.1639 2.4757 1.9615
YAPC GDSC1; GDSC2 5.0318 6.5774 2.8041 0.5254
QGP-1 GDSC1 5.2586 6.8505 2.7951 0.4967
HPAF-II GDSC1; GDSC2 6.1279 8.6575 2.4747 0.8546
SNU-410 CTRP2 6.5492 13.8487 1.8247 11.4473
KP-4 CTRP2 7.1183 8.7211 5.4596 1.0037
SNU-213 CTRP2 7.3309 13.0194 3.5623 8.1653
Panc 08.13 CTRP2 7.4041 9.4597 5.2925 1.3093
CFPAC-1 CTRP2 7.4067 11.878 4.17 5.6007
PaTu 8988t CTRP2 7.4748 8.7355 5.6234 0.3037
PK-45H CTRP2 7.6002 10.6233 4.8848 2.5642
QGP-1 CTRP2 7.6379 9.1684 5.5271 0.4487
PSN1 CTRP2 7.7577 10.1801 5.1694 1.4085
YAPC CTRP2 7.8132 9.1332 5.6124 0.2053
PaTu 8988s CTRP2 7.8753 9.643 5.4465 0.5239
DAN-G CTRP2 7.9041 9.5815 5.4826 0.4266
SUIT-2 CTRP2 7.9278 9.8796 5.3769 0.6706
MIA PaCa-2 CTRP2 7.9286 9.2211 5.6248 0.1561
TCC-Pan2 CTRP2 7.9439 9.5516 5.5104 0.3506
HPAF-II CTRP2 8.0004 10.122 5.3135 0.7969
Hs 766T CTRP2 8.015 9.6553 5.5008 0.3429
PaTu 8902 CTRP2 8.0332 9.106 5.7018 0.0549
Capan-2 CTRP2 8.0493 9.8223 5.4521 0.4304
L3.3 CTRP2 8.0697 9.3346 5.6369 0.1121
HuP-T4 CTRP2 8.1133 9.6194 5.5527 0.218
KP-2 CTRP2 8.1191 9.2576 5.6805 0.0624
AsPC-1 CTRP2 8.2373 10.1422 5.4096 0.443
Capan-1 CTRP2 8.2804 9.8749 5.5249 0.217
Panc 04.03 CTRP2 8.4009 10.1176 5.4839 0.249
Panc 05.04 CTRP2 8.4251 10.0433 5.5195 0.1899
HPAC CTRP2 8.4393 9.945 5.5591 0.1365
Panc 03.27 CTRP2 8.6794 10.2588 5.537 0.121
HuP-T3 CTRP2 8.7138 15.8354 3.1548 7.7645
SW1990 CTRP2 8.7221 10.4117 5.4997 0.1551
KP-3 CTRP2 8.7233 10.6228 5.4259 0.2541
Panc 02.03 CTRP2 8.7284 10.305 5.5385 0.1122
BxPC-3 CTRP2 8.9577 10.99 5.3836 0.2587
PK-59 CTRP2 9.1825 17.009 2.9047 8.0821
Panc 10.05 CTRP2 9.2262 11.2063 5.4066 0.1733
SU.86.86 CTRP2 10.5937 39.9028 -7.2591 29.2774
⏷ Show the Full List of 68 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 108 Cell Line(s) in Skin Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
SH4 CTRP2 11.0636 24.7786 0.4574 13.7322
G-mel GDSC1 0.5179 4.8382 -0.2536 32.5598
RPMI-7951 GDSC1; GDSC2 1.6595 4.6428 1.0316 17.819
A-375 GDSC1; GDSC2 1.8671 3.9049 1.5441 14.4439
SK-MEL-30 GDSC1 1.9031 7.2846 0.062 24.9328
A101D GDSC1; GDSC2 1.9916 5.9678 0.7748 18.001
A2058 GDSC1; GDSC2 2.1446 4.4618 1.6133 13.077
LOX-IMVI GDSC1; GDSC2 2.2632 5.1219 1.4374 13.6046
MZ-MEL-2 GDSC1 2.2786 7.504 0.3084 22.247
WM1552C GDSC1; GDSC2 2.4209 4.6729 1.8013 11.136
SK-MEL-5 GDSC1 2.4669 5.5806 1.4196 15.1037
WT2-iPS GDSC1; GDSC2 2.5402 5.1153 1.7124 11.2265
COLO 792 GDSC1; GDSC2 2.5447 5.4386 1.5622 12.028
WM793 GDSC1; GDSC2 2.6536 6.4495 1.1713 13.8223
Mel Ho GDSC1 2.693 5.243 1.7975 11.9191
Hs 940.T GDSC1 2.7187 8.5794 0.175 21.3825
COLO 829 GDSC1; GDSC2 2.8256 4.9574 2.061 8.4352
451Lu GDSC1 2.9731 6.4433 1.4618 13.0906
CHL-1 GDSC1; GDSC2 3.0089 5.9887 1.7195 9.791
WM35 GDSC1; GDSC2 3.0756 6.0111 1.7669 9.3428
COLO 679 GDSC1; GDSC2 3.0758 4.9587 2.2904 6.4308
COLO 800 GDSC1 3.1653 4.5511 2.5723 5.3444
IST-MEL1 GDSC1; GDSC2 3.231 5.5723 2.1201 6.9552
UACC-62 GDSC1; GDSC2 3.2629 5.4553 2.2056 6.393
HT-144 GDSC1; GDSC2 3.2895 6.276 1.8178 8.4883
IPC-298 GDSC1 3.3082 4.0507 2.9461 2.4766
WM278 GDSC1; GDSC2 3.3365 5.3322 2.3289 5.5139
G-361 GDSC1; GDSC2 3.419 5.2222 2.4514 4.6225
MeWo GDSC1; GDSC2 3.4678 5.0982 2.5523 3.9423
SK-MEL-28 GDSC1 3.5394 6.5806 1.8701 8.7692
IGR-37 GDSC1; GDSC2 3.5652 6.0331 2.1634 5.8779
SK-MEL-2 GDSC1; GDSC2 3.6544 6.1483 2.1754 5.6044
A-388 GDSC1 3.6711 5.9678 2.2775 5.7964
HMV-II GDSC1; GDSC2 3.6743 5.8462 2.3401 4.6474
SK-MEL-24 GDSC1; GDSC2 3.6778 7.6767 1.4336 9.6502
UACC-257 GDSC1; GDSC2 3.7863 5.7257 2.4816 3.631
M14 GDSC1; GDSC2 3.8157 6.2437 2.2493 4.8408
SK-MEL-1 GDSC1; GDSC2 3.8188 6.0635 2.34 4.3376
SK-MEL-31 GDSC1 3.9667 6.6955 2.1376 5.9518
A-431 GDSC1 4.043 7.0127 2.0375 6.401
RVH-421 GDSC1 4.0889 8.9133 1.1368 11.8468
Hs 938.T GDSC1 4.1184 12.655 -0.6985 21.2091
WM115 GDSC1; GDSC2 4.1791 10.5551 0.3925 13.9144
VMRC-MELG GDSC1 4.3085 6.0661 2.6587 2.1004
COLO 783 GDSC1 4.4152 9.6661 1.0084 11.7723
SH-4 GDSC1; GDSC2 4.5055 8.1215 1.8225 5.7789
LB2518-MEL GDSC1 4.594 5.7557 2.9321 0.4689
CP50-MEL-B GDSC1 4.7839 8.2533 1.9421 5.3988
Mel JuSo GDSC1; GDSC2 4.7873 11.0195 0.6155 11.4777
IGR-1 GDSC1; GDSC2 4.7888 7.605 2.2441 3.1386
GAK GDSC1; GDSC2 4.8033 6.4499 2.7523 0.8615
DJM-1 GDSC1 5.097 11.6686 0.5193 12.862
SK-MEL-3 GDSC1 5.0981 7.4407 2.4866 1.8955
MMAc-SF GDSC1 5.2421 6.8751 2.7792 0.5556
MZ-MEL-7 GDSC1 5.3742 7.3198 2.6656 0.8544
LB373-MEL-D GDSC1 5.5451 15.3739 -0.9667 18.767
CP66-MEL GDSC1 5.7744 12.9766 0.3538 12.2361
LOX-IMVI CTRP2 6.2271 8.6901 4.8705 4.5927
SK-MEL-28 CTRP2 6.7367 7.992 5.5691 0.9917
SK-MEL-2 CTRP2 6.982 8.7629 5.3642 1.4767
Hs 839.T CTRP2 7.1129 8.0266 5.7405 0.2044
Hs 944.T CTRP2 7.1245 9.2346 4.3252 0.7439
WM1799 CTRP2 7.1893 9.4168 5.1898 1.8918
G-361 CTRP2 7.2593 9.1992 5.3274 1.3246
SK-MEL-1 CTRP2 7.3081 8.5906 5.6073 0.4224
K029AX CTRP2 7.3438 9.123 5.4056 0.9877
HMCB CTRP2 7.3841 8.7455 5.5803 0.4496
CJM [Human melanoma] CTRP2 7.3943 9.417 5.3058 1.2733
COLO 741 CTRP2 7.4237 10.8221 4.684 3.5395
WM266-4 CTRP2 7.4386 8.9001 5.5437 0.5139
Mel Ho CTRP2 7.4438 9.7804 5.1734 1.6834
A-375 CTRP2 7.4564 11.9644 4.1624 5.56
WM115 CTRP2 7.6151 9.033 5.5694 0.3614
COLO 792 CTRP2 7.6199 10.5789 4.9166 2.4254
IGR-37 CTRP2 7.6313 9.0527 5.5688 0.3556
Mel JuSo CTRP2 7.6836 9.2478 5.5162 0.4521
WM793 CTRP2 7.7108 10.0457 5.2025 1.3403
UACC-62 CTRP2 7.7205 8.7289 5.7204 0.0783
SK-MEL-24 CTRP2 7.7226 10.2549 5.1185 1.609
IPC-298 CTRP2 7.7274 8.9208 5.6558 0.1596
SK-MEL-5 CTRP2 7.7313 9.0289 5.6183 0.2199
WT2-iPS CTRP2 7.7645 9.0133 5.6368 0.1793
UACC-257 CTRP2 7.788 10.9647 4.8405 2.5227
RPMI-7951 CTRP2 7.8076 9.2581 5.5644 0.2942
Hs 294T CTRP2 7.8224 9.0647 5.6404 0.1589
SK-MEL-31 CTRP2 7.8316 9.0975 5.6322 0.1688
SK-MEL-30 CTRP2 7.8443 9.0667 5.6479 0.143
IGR-1 CTRP2 7.8976 9.5556 5.4896 0.4138
Hs 934.T CTRP2 7.9404 9.039 5.6922 0.0743
COLO 829 CTRP2 7.9467 10.9519 4.9359 2.025
Hs 852.T CTRP2 7.9628 9.9581 5.3616 0.6907
SK-MEL-3 CTRP2 7.9663 9.6158 5.4955 0.3724
IGR-39 CTRP2 7.9666 9.1224 5.673 0.0896
Hs 936.T CTRP2 8.003 9.3149 5.6194 0.1469
A101D CTRP2 8.0128 9.0941 5.6988 0.0595
MDA-MB-435S CTRP2 8.0426 9.4706 5.579 0.1956
RVH-421 CTRP2 8.1056 9.3663 5.6388 0.1038
WM88 CTRP2 8.1311 12.0674 4.5429 3.2401
A2058 CTRP2 8.134 9.3967 5.6385 0.0996
MeWo CTRP2 8.1902 9.9686 5.4553 0.3676
Hs 895.T CTRP2 8.2005 9.4233 5.6529 0.0762
HT-144 CTRP2 8.2105 9.9791 5.4596 0.3519
Hs 688(A).T CTRP2 8.2443 18.1455 1.7149 13.7151
COLO 800 CTRP2 8.2838 9.9452 5.501 0.2541
Hs 940.T CTRP2 8.3419 10.1263 5.4578 0.3106
WM983B CTRP2 8.4249 10.6145 5.309 0.5827
Malme-3M CTRP2 8.5158 11.2033 5.1181 1.0146
EquiPSC Line K2 GDSC1 7.0812 22.295 -3.2435 23.1086
⏷ Show the Full List of 108 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 11 Cell Line(s) in Aero Dig Tract Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
KYSE-220 GDSC1; GDSC2 1.3604 4.282 0.8595 19.7951
HCE-4 GDSC1 2.7516 6.1193 1.4236 14.0704
FLO-1 GDSC1; GDSC2 3.2271 6.4669 1.6698 9.4752
OACP4 C GDSC1; GDSC2 3.2907 7.5305 1.1915 11.9391
ESO-26 GDSC1; GDSC2 3.3961 6.1229 1.9827 7.2966
TE-12 GDSC1 3.7145 7.9198 1.3414 11.613
KYAE-1 GDSC1; GDSC2 3.8488 5.5124 2.6286 2.7137
SK-GT-4 GDSC1; GDSC2 4.2652 8.007 1.7113 6.8398
OACM5.1 C GDSC1; GDSC2 4.7345 9.5353 1.2991 8.097
KYSE-50 GDSC1; GDSC2 5.2329 6.9042 2.7645 0.5254
ESO-51 GDSC1; GDSC2 5.2456 7.7876 2.4152 1.7796
⏷ Show the Full List of 11 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 2 Cell Line(s) in Ascites Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
COLO 684 GDSC1; GDSC2 3.9195 6.8021 2.0512 5.7071
COLO 684 CTRP2 7.8437 12.4568 4.1851 4.9436
Cancer Drug Sensitivity Data Curated from 44 Cell Line(s) in Autonomic Ganglia Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
CHP-134 GDSC2 0.4984 2.8779 0.2215 21.1696
SK-N-MC-IXC GDSC1 0.8844 2.1549 0.8676 25.1208
NB69 GDSC1; GDSC2 1.9142 4.3166 1.4336 14.8319
SiMa GDSC1; GDSC2 1.9987 4.2742 1.54 13.9781
GOTO GDSC1; GDSC2 2.1132 5.8623 0.9434 16.7213
IMR-5 GDSC1; GDSC2 2.1987 3.8756 1.9104 11.3485
MHH-NB-11 GDSC1 2.2728 4.0281 1.9289 15.4911
SJNB-5 GDSC1 2.3035 7.2607 0.4506 21.3942
NH-12 GDSC1; GDSC2 2.3392 5.2339 1.4603 13.2332
SJNB-10 GDSC1; GDSC2 2.4675 5.8234 1.3033 13.6723
CHP-126 GDSC1 2.5192 5.1629 1.6694 13.3552
KP-N-YN GDSC1; GDSC2 2.8108 7.1142 0.9847 14.3685
SJNB-14 GDSC1; GDSC2 2.8487 5.2452 1.9421 9.0199
Kelly GDSC1; GDSC2 2.8699 7.5547 0.818 15.0851
SK-N-SH GDSC1; GDSC2 2.9215 7.4147 0.9329 14.331
SJNB-13 GDSC1; GDSC2 3.0093 7.3018 1.0658 13.3745
NB1 GDSC1; GDSC2 3.0653 4.9276 2.2963 6.4274
CHP-212 GDSC1; GDSC2 3.1624 8.3578 0.6698 15.0513
GI-ME-N GDSC1; GDSC2 3.5597 8.058 1.149 11.4846
SK-N-AS GDSC1; GDSC2 3.5863 6.6988 1.8484 7.5793
SJNB-7 GDSC1; GDSC2 3.5992 6.2063 2.1038 6.1296
TGW GDSC1; GDSC2 3.752 6.7282 1.9626 6.5619
SK-N-BE(2)-M17 GDSC1; GDSC2 3.8321 7.1429 1.8182 7.1782
SJNB-6 GDSC1 4.0919 5.9609 2.5756 2.9673
NB(TU)1 GDSC1; GDSC2 4.1566 7.094 2.0781 5.0791
LA-N-6 GDSC1 4.3999 6.762 2.3957 3.4501
SJNB-12 GDSC1; GDSC2 4.4853 7.6283 2.044 4.6489
SJNB-17 GDSC1 4.6364 10.0386 0.986 11.3638
SK-N-FI GDSC1; GDSC2 4.8844 9.8787 1.2366 8.1335
SK-N-DZ GDSC1; GDSC2 5.2635 18.7113 -2.8206 23.7535
KP-N-YS GDSC1 5.8386 8.056 2.5816 1.0008
SK-N-DZ CTRP2 6.4418 10.1617 4.3068 6.5707
IMR-32 CTRP2 6.6226 11.2298 3.9164 7.8808
SK-N-SH CTRP2 7.2982 10.5289 4.7411 3.4779
Kelly CTRP2 7.3715 11.4736 4.3403 4.9683
CHP-126 CTRP2 7.3769 9.1676 4.4565 0.3233
NB1 CTRP2 7.4173 11.2575 4.4741 4.3724
KP-N-YN CTRP2 7.6299 10.8449 4.8015 2.841
SK-N-FI CTRP2 7.6584 9.3027 5.4836 0.5457
SK-N-BE(2) CTRP2 7.7192 13.7926 3.4617 7.9741
NH-6 CTRP2 7.8456 9.5052 5.4868 0.4434
KP-N-SI9s CTRP2 8.0728 18.2114 1.5574 14.5316
CHP-212 CTRP2 8.1601 9.7803 5.5127 0.2711
SK-N-AS CTRP2 8.3797 9.8852 5.5582 0.1487
⏷ Show the Full List of 44 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 7 Cell Line(s) in Biliary Tract Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
HuCC-T1 GDSC1; GDSC2 4.8255 10.569 0.8621 10.1641
HuH-28 CTRP2 7.0903 8.9531 5.3415 1.4435
SNU-869 CTRP2 7.6117 9.3479 5.4441 0.6786
SNU-478 CTRP2 7.6814 9.4531 5.4342 0.6627
SNU-1196 CTRP2 8.2702 9.7942 5.5497 0.183
HuCC-T1 CTRP2 8.281 9.828 5.5418 0.1918
SNU-1079 CTRP2 8.4573 10.2541 5.4565 0.2778
⏷ Show the Full List of 7 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 124 Cell Line(s) in Breast Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
CAL-148 GDSC2 1.7305 3.5102 1.3024 10.3586
HCC1599 GDSC1; GDSC2 2.0005 3.9991 1.0008 6.3026
MDA-MB-468 GDSC1; GDSC2 2.3963 5.8758 1.2103 14.3523
HCC1806 GDSC1; GDSC2 2.4829 6.0913 1.1882 14.2028
CAL-51 GDSC1; GDSC2 2.5603 4.9934 1.7898 10.7091
MDA-MB-436 GDSC1; GDSC2 2.6326 4.2131 2.2231 8.151
HCC70 GDSC1; GDSC2 2.6985 4.7829 2.0238 9.005
HCC1187 GDSC1; GDSC2 3.0941 3.9451 2.8048 3.5229
BT-20 GDSC1; GDSC2 3.3344 4.375 2.8057 2.8448
Evsa-T GDSC1; GDSC2 3.3557 5.2018 2.41 4.9958
BT-549 GDSC1; GDSC2 3.3784 9.1729 0.4434 15.5878
UACC-812 GDSC2 3.4319 6.5275 1.2671 5.8138
MDA-MB-361 GDSC1; GDSC2 3.4381 5.0663 2.5445 4.0439
MCF-7 GDSC1; GDSC2 3.4888 5.5754 2.3311 5.1091
DU4475 GDSC1; GDSC2 3.5036 6.2879 1.9875 6.9831
UACC-893 GDSC1; GDSC2 3.5138 5.7615 2.2582 5.4548
MDA-MB-175-VII GDSC1; GDSC2 3.562 6.8257 1.7659 8.071
HCC2157 GDSC1; GDSC2 3.6768 5.6602 2.4337 4.1125
AU565 GDSC1; GDSC2 3.7267 6.9175 1.8494 7.2229
HCC1143 GDSC1; GDSC2 3.7429 5.8121 2.4079 4.1123
JIMT-1 GDSC1; GDSC2 3.8013 7.8368 1.4505 9.2386
HCC1395 GDSC1; GDSC2 3.8115 7.6092 1.5714 8.5557
MDA-MB-231 GDSC1; GDSC2 3.8208 6.6893 2.0338 5.9972
MDA-MB-415 GDSC1; GDSC2 3.8344 5.5988 2.5771 3.0081
HCC1419 GDSC1; GDSC2 3.941 8.2645 1.3457 9.4869
HDQ-P1 GDSC1; GDSC2 3.9465 6.2041 2.3623 3.945
CAL-85-1 GDSC1; GDSC2 3.9853 5.9647 2.5041 3.1131
EFM-192A GDSC1; GDSC2 4.0368 5.6025 2.7081 1.9661
ZR-75-30 GDSC1; GDSC2 4.1662 5.8945 2.6526 2.0429
CAMA-1 GDSC1; GDSC2 4.2402 8.1245 1.6363 7.2729
HCC202 GDSC1; GDSC2 4.2789 8.6146 1.4246 8.327
HCC1954 GDSC1; GDSC2 4.3362 6.2887 2.5743 2.1755
MFM-223 GDSC1; GDSC2 4.347 6.6652 2.4078 2.9909
HCC38 GDSC1; GDSC2 4.4089 6.9839 2.2981 3.4497
CAL-120 GDSC1; GDSC2 4.4106 7.9604 1.8353 5.8718
Hs 578T GDSC1; GDSC2 4.6376 10.5313 0.7463 11.1045
MRK-nu-1 GDSC1; GDSC2 4.8798 7.1276 2.507 1.7826
MDA-MB-157 GDSC1; GDSC2 4.9144 7.4037 2.4056 2.1945
EFM-19 GDSC1; GDSC2 4.9848 7.1485 2.5523 1.4747
HCC1937 GDSC1; GDSC2 4.9869 8.8191 1.806 5.0078
OCUB-M GDSC1; GDSC2 5.0171 7.3247 2.4943 1.6839
HCC1428 GDSC1; GDSC2 5.0244 6.6548 2.7711 0.6296
MDA-MB-157 CTRP2 5.0498 9.0308 3.6585 12.124
BT-474 GDSC1; GDSC2 5.1754 6.5014 2.8898 0.2416
MDA-MB-453 GDSC1; GDSC2 5.3055 7.338 2.6281 0.905
T-47D GDSC1; GDSC2 5.331 7.2117 2.6887 0.6905
HCC1569 GDSC1; GDSC2 5.3959 9.1833 1.8861 3.9907
BT-483 GDSC1; GDSC2 5.4588 7.6504 2.5737 0.9777
HCC2218 GDSC1; GDSC2 5.5384 7.2675 2.7532 0.4039
HCC1500 GDSC1; GDSC2 5.6331 7.0241 2.8749 0.1434
COLO 824 GDSC1; GDSC2 5.6356 8.1158 2.4691 1.2076
MDA-MB-330 GDSC1; GDSC2 6.6722 9.1397 2.5154 0.4898
KPL-1 CTRP2 6.9524 7.6924 5.7998 0.1465
MDA-MB-415 CTRP2 7.0674 9.0508 5.2839 1.6787
SK-BR-3 CTRP2 7.2747 11.5695 4.2278 5.5595
CAL-120 CTRP2 7.3817 8.8731 5.5282 0.5903
CAMA-1 CTRP2 7.3899 9.0253 5.4698 0.7531
Hs 578Bst CTRP2 7.5146 9.8824 5.1678 1.6341
JIMT-1 CTRP2 7.5576 9.4649 5.3699 0.9324
HCC1806 CTRP2 7.559 18.1814 1.1873 16.6346
UACC-812 CTRP2 7.6654 9.5923 5.37 0.8545
ZR-75-1 CTRP2 7.6696 9.0722 5.5774 0.3209
HCC1428 CTRP2 7.6707 8.7304 5.7019 0.1084
HDQ-P1 CTRP2 7.6711 9.2349 5.5158 0.4593
DU4475 CTRP2 7.6816 13.2081 3.7181 7.0112
HCC38 CTRP2 7.7139 9.6028 5.389 0.7676
HCC1143 CTRP2 7.7883 11.1307 4.7657 2.7963
CAL-148 CTRP2 7.8235 9.1736 5.6017 0.2202
Hs 578T CTRP2 7.9042 9.9316 5.3453 0.7689
HMC-1-8 CTRP2 7.9468 9.0298 5.6976 0.0685
HCC1419 CTRP2 7.9582 9.68 5.4679 0.4354
BT-474 CTRP2 7.9901 9.3456 5.6037 0.1718
HCC1500 CTRP2 8.0993 9.8807 5.4509 0.4122
HCC2218 CTRP2 8.113 9.748 5.5059 0.2984
HCC1937 CTRP2 8.1591 10.6277 5.1832 1.0608
AU565 CTRP2 8.1668 11.2796 4.9123 1.9041
MCF-7 CTRP2 8.2106 10.8176 5.13 1.1808
HCC1395 CTRP2 8.2353 10.9386 5.0921 1.2765
ZR-75-30 CTRP2 8.2663 10.0094 5.4708 0.3117
EFM-192A CTRP2 8.3381 9.9344 5.5255 0.2017
MDA-MB-361 CTRP2 8.3678 11.3558 4.9839 1.5081
HCC202 CTRP2 8.3972 10.7591 5.2407 0.7606
CAL-51 CTRP2 8.4203 9.8935 5.57 0.1273
MDA-MB-468 CTRP2 8.4269 9.8648 5.5823 0.1129
MDA-MB-453 CTRP2 8.4802 10.0473 5.5384 0.1537
MDA-MB-231 CTRP2 8.488 10.5373 5.3646 0.4366
BT-20 CTRP2 8.5819 10.1159 5.5513 0.1212
CAL-85-1 CTRP2 8.7007 14.287 3.8702 5.0891
BT-549 CTRP2 8.7658 10.6627 5.4277 0.2408
HCC1954 CTRP2 8.9608 10.8382 5.4382 0.1844
T-47D CTRP2 9.0028 11.075 5.3704 0.267
BT 112 CTRP2 7.1531 8.8223 5.4343 1.0574
BT 416 CTRP2 7.3062 8.8351 5.5075 0.7005
BT 131 CTRP2 7.4124 9.2546 5.385 0.9979
BT 232 CTRP2 7.426 15.8955 2.2175 13.2455
BT 498 CTRP2 7.4406 8.4821 5.7036 0.1618
BT 159 CTRP2 7.449 9.1067 5.465 0.726
BT 286 CTRP2 7.5123 9.4132 5.3689 0.9699
BT 422 CTRP2 7.5314 9.3628 5.3994 0.8621
BT147 CTRP2 7.5346 9.5462 5.3241 1.0935
BT 216 CTRP2 7.5512 9.4044 5.3919 0.8705
BT 239 CTRP2 7.5561 11.7145 4.3485 4.682
BT 320 CTRP2 7.5775 8.7842 5.6471 0.2178
BT 340 CTRP2 7.5972 9.04 5.5591 0.3929
BT 224 CTRP2 7.6552 9.2872 5.4882 0.5358
BT 444 CTRP2 7.6727 8.7511 5.6954 0.1164
BT 504 CTRP2 7.6914 11.8941 4.3518 4.4905
BT 359 CTRP2 7.7383 10.105 5.1914 1.3532
BT 428 CTRP2 7.8433 9.2443 5.5837 0.2456
BT164 CTRP2 7.913 9.2536 5.6074 0.1858
BT 248 CTRP2 7.9777 9.4156 5.574 0.2215
BT 328 CTRP2 7.9846 9.121 5.6799 0.08
BT 482 CTRP2 8.0149 9.3052 5.6272 0.1342
BT 179 CTRP2 8.0223 9.1268 5.6911 0.0648
BT 139 CTRP2 8.0617 9.2202 5.6732 0.0757
BT 330 CTRP2 8.1586 21.09 0.2027 18.6837
BT 333 CTRP2 8.1642 9.4989 5.6142 0.1216
BT 440 CTRP2 8.2204 10.5154 5.2573 0.8167
BT 231 CTRP2 8.2616 10.9 5.1209 1.1721
BT 245 CTRP2 8.3363 10.3376 5.377 0.4712
BT 145 CTRP2 8.402 9.7695 5.606 0.0928
BT 228 CTRP2 8.4737 10.3543 5.4264 0.3243
BT 172 CTRP2 8.8558 18.19 2.1248 11.3511
BT 271 CTRP2 10.1794 22.4995 0.9554 13.3938
⏷ Show the Full List of 124 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 1 Cell Line(s) in Tongue Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
YD-38 CTRP2 7.4786 8.3928 5.7494 0.0869
Cancer Drug Sensitivity Data Curated from 100 Cell Line(s) in Central Nervous System Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
Daoy GDSC1; GDSC2 0.4831 3.5719 0.1521 26.6732
GB-1 GDSC1; GDSC2 0.6496 4.1306 0.1506 25.999
GI-1 GDSC1; GDSC2 0.8571 3.8107 0.4842 23.587
D283 Med GDSC1; GDSC2 1.3074 3.5871 1.0457 19.0793
MOG-G-UVW GDSC1; GDSC2 1.3306 3.7264 1.0262 19.0829
D-566MG GDSC1 1.4986 4.5937 0.883 22.1775
SF268 GDSC1; GDSC2 1.7693 4.7441 1.1034 17.0558
H4 GDSC1; GDSC2 2.094 5.6731 1.0136 16.4144
SF539 GDSC1; GDSC2 2.1534 4.9461 1.4081 14.1278
ONS-76 GDSC1; GDSC2 2.2176 6.6495 0.6673 17.826
YKG-1 GDSC1 2.4135 4.7499 1.7587 13.1989
MOG-G-CCM GDSC1; GDSC2 2.5194 4.6063 1.9304 10.1174
8-MG-BA GDSC1; GDSC2 2.5573 5.2451 1.6671 11.4181
D-263MG GDSC1; GDSC2 2.7982 4.9376 2.0447 8.608
AM-38 GDSC1; GDSC2 2.862 4.2187 2.4497 6.2005
SK-MG-1 GDSC1; GDSC2 2.9034 6.1492 1.546 11.0484
D-247MG GDSC1 2.9116 6.3448 1.4563 13.327
LN-18 GDSC1; GDSC2 2.9309 4.625 2.3214 6.6844
SF295 GDSC1 3.0324 6.2213 1.6245 11.8697
M059J GDSC1; GDSC2 3.0438 6.7341 1.3789 11.5758
SF126 GDSC1 3.0488 5.7386 1.8791 10.1893
SW1783 GDSC1; GDSC2 3.0729 6.2684 1.6364 10.075
SW1088 GDSC1; GDSC2 3.1961 5.8921 1.9305 8.106
NMC-G1 GDSC1 3.2698 11.2958 -0.7086 23.7144
U-251MG GDSC1; GDSC2 3.2781 6.2023 1.8451 8.3661
D-392MG GDSC1; GDSC2 3.3298 5.8598 2.0595 7.036
D-423MG GDSC1 3.3726 7.4766 1.2866 12.937
DBTRG-05MG GDSC1; GDSC2 3.457 5.2927 2.4467 4.5565
U-118MG GDSC1; GDSC2 3.4643 7.0147 1.5928 9.2941
LN-229 GDSC1; GDSC2 3.4804 5.8808 2.172 6.0321
YH-13 GDSC1; GDSC2 3.4854 7.0376 1.5985 9.2101
Hs 683 GDSC1 3.4932 4.8683 2.6865 3.6354
LN-405 GDSC1; GDSC2 3.5039 5.4955 2.3829 4.8002
LNZTA3WT4 GDSC1; GDSC2 3.554 6.2117 2.0656 6.4486
Onda 11 GDSC1 3.5847 9.6322 0.383 17.5386
U-87MG ATCC GDSC1; GDSC2 3.5954 6.7724 1.819 7.7209
42-MG-BA GDSC1; GDSC2 3.6551 7.701 1.4035 9.8691
DK-MG GDSC1; GDSC2 3.7664 5.9941 2.3357 4.4713
D-542MG GDSC1 3.7908 6.7321 1.9901 7.3249
Becker GDSC1; GDSC2 3.8015 7.4999 1.6179 8.3497
KNS-42 GDSC1 3.8543 7.209 1.8022 8.3536
D-336MG GDSC1 3.8896 7.0258 1.9192 7.523
KS-1 [Human Krukenberg tumour] GDSC1; GDSC2 4.039 7.8596 1.6194 7.8118
PFSK-1 GDSC1; GDSC2 4.1591 9.6489 0.8262 11.7721
D-502MG GDSC1 4.2815 10.1995 0.6464 14.1666
KALS-1 GDSC1; GDSC2 4.516 10.3855 0.7291 11.4816
SNB-75 GDSC1 4.5808 11.2534 0.3502 14.9955
KINGS-1 GDSC1; GDSC2 4.6807 9.5926 1.2341 8.5412
CAS-1 GDSC1; GDSC2 4.8634 7.4153 2.3723 2.4205
T98G GDSC1; GDSC2 4.9504 8.9813 1.707 5.5892
A-172 GDSC1; GDSC2 5.236 9.6675 1.5671 5.8216
Onda 10 GDSC1 5.5015 14.3745 -0.5101 16.9334
KNS-81-FD GDSC1 5.6554 7.8279 2.591 0.9161
D283 Med CTRP2 6.0398 8.9875 4.569 6.2102
SNU-466 CTRP2 6.0551 10.2257 3.9626 8.7251
GaMG GDSC1; GDSC2 6.1222 13.9914 0.1017 11.3393
LN-18 CTRP2 7.1228 8.4963 5.5578 0.6826
CCF-STTG1 CTRP2 7.333 8.629 5.6033 0.419
SW1783 CTRP2 7.3412 9.2241 5.3609 1.1362
CAS-1 CTRP2 7.3491 13.2518 3.4618 8.5406
SNU-201 CTRP2 7.4048 8.9065 5.5255 0.5831
SNU-489 CTRP2 7.4749 8.8833 5.5666 0.4355
GMS-10 CTRP2 7.5299 8.5507 5.713 0.1239
GB-1 CTRP2 7.5361 10.6813 4.8197 2.8809
KNS-42 CTRP2 7.5417 9.2263 5.4604 0.6776
U-87MG ATCC CTRP2 7.6262 8.9782 5.5948 0.3021
SF126 CTRP2 7.6655 18.8726 0.9262 17.3016
SNU-1105 CTRP2 7.6779 8.6704 5.7253 0.0798
KG-1-C CTRP2 7.7056 8.9868 5.6236 0.2186
Daoy CTRP2 7.7122 10.2818 5.1011 1.6777
LN-229 CTRP2 7.7126 10.2023 5.1359 1.5593
GaMG CTRP2 7.7134 9.1472 5.5673 0.3245
SF539 CTRP2 7.7422 9.4819 5.4505 0.5843
SNU-626 CTRP2 7.7504 9.1393 5.5854 0.2742
Becker CTRP2 7.8361 9.8509 5.346 0.8096
DK-MG CTRP2 7.8591 9.3428 5.5537 0.2962
Hs 683 CTRP2 7.8924 9.4931 5.5111 0.3697
SF295 CTRP2 7.9061 9.3591 5.5665 0.2562
SNU-738 CTRP2 8.0446 9.731 5.4846 0.3642
NMC-G1 CTRP2 8.058 9.4121 5.6056 0.1535
M059K CTRP2 8.064 9.4093 5.6088 0.1479
T98G CTRP2 8.069 9.7381 5.4919 0.3405
YKG-1 CTRP2 8.0982 9.129 5.7163 0.039
TM-31 CTRP2 8.1157 9.1294 5.722 0.0343
U-251MG CTRP2 8.1271 9.5392 5.5865 0.1644
A-172 CTRP2 8.1473 9.8031 5.4993 0.2991
DBTRG-05MG CTRP2 8.2208 9.9739 5.4657 0.3366
ONS-76 CTRP2 8.2245 9.8374 5.517 0.2447
AM-38 CTRP2 8.2437 10.082 5.4348 0.3885
YH-13 CTRP2 8.3045 10.0042 5.4876 0.2703
42-MG-BA CTRP2 8.3847 10.4929 5.3384 0.5346
U-118MG CTRP2 8.4994 10.3811 5.4268 0.3156
SNB-75 CTRP2 8.5481 10.6437 5.3494 0.4443
SF268 CTRP2 8.5564 10.7948 5.2959 0.5533
8-MG-BA CTRP2 8.583 10.2691 5.4986 0.1837
SW1088 CTRP2 8.7385 10.3224 5.5362 0.1131
GOS-3 CTRP2 9.2452 10.8552 5.5319 0.0615
KNS-81 CTRP2 10.0963 32.6856 -4.0686 25.3357
KALS-1 CTRP2 11.8885 22.9031 1.8437 8.5437
KNS-60 CTRP2 13.5985 36.6464 -3.511 20.0196
⏷ Show the Full List of 100 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 3 Cell Line(s) in Digestive System Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
TGBC1TKB GDSC1; GDSC2 3.5323 5.2276 2.5382 3.8701
TGBC24TKB GDSC1; GDSC2 3.8874 5.4463 2.686 2.3384
ETK-1 GDSC1; GDSC2 4.0435 7.4736 1.8124 6.7503
Cancer Drug Sensitivity Data Curated from 30 Cell Line(s) in Endometrium Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
ESS-1 GDSC1; GDSC2 1.1095 4.0602 0.6721 21.6825
MFE-296 GDSC1; GDSC2 3.2967 4.2635 2.83 2.8155
AN3-CA GDSC1; GDSC2 3.3138 6.2445 1.8538 8.225
RL95-2 GDSC1; GDSC2 4.1343 8.5576 1.3464 9.0811
EN GDSC1; GDSC2 4.185 6.4509 2.405 3.2872
MFE-280 GDSC1; GDSC2 4.7083 7.0733 2.4368 2.3227
KLE GDSC1; GDSC2 4.7094 7.6261 2.1868 3.5428
MFE-319 GDSC1; GDSC2 6.1598 7.5659 2.8746 0.0669
JHUEM-2 CTRP2 6.3827 8.7892 4.9427 4.0175
KLE CTRP2 6.9495 10.8688 4.3386 5.5989
HEC-265 CTRP2 7.3658 8.6707 5.6015 0.4061
JHUEM-7 CTRP2 7.4398 9.1373 5.4479 0.7828
HEC-1-B CTRP2 7.44 9.2167 5.4149 0.8826
HEC-251 CTRP2 7.4902 10.2957 4.9686 2.3762
JHUEM-1 CTRP2 7.6683 8.8433 5.661 0.167
HEC-59 CTRP2 7.803 16.2203 2.3373 12.1802
MFE-296 CTRP2 7.8227 11.1449 4.7795 2.7081
EFE-184 CTRP2 7.8925 9.2477 5.6017 0.2003
AN3-CA CTRP2 7.9433 9.9239 5.3664 0.6893
HEC-151 CTRP2 7.9779 9.4053 5.5778 0.2152
RL95-2 CTRP2 8.0499 9.3898 5.6104 0.1488
ESS-1 CTRP2 8.0524 9.6748 5.5086 0.314
JHUEM-3 CTRP2 8.0706 10.6333 5.1376 1.2596
HEC-6 CTRP2 8.0765 9.4462 5.6005 0.1565
EN CTRP2 8.3012 9.8857 5.5289 0.2057
MFE-319 CTRP2 8.4523 9.8914 5.5822 0.1091
HEC-1-A CTRP2 8.5574 12.6445 4.5286 2.853
HEC-50B CTRP2 10.6241 23.3971 -0.0035 12.0499
HEC-108 CTRP2 18.2212 44.5649 -4.2616 16.817
Ishikawa (Heraklio) 02 ER- CTRP2 15.1729 36.4106 -2.3728 16.0614
⏷ Show the Full List of 30 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 53 Cell Line(s) in Kidney Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
KTCTL-1M GDSC1 -0.04 4.8998 -0.8728 37.8812
KTCTL-140 GDSC1 0.0228 4.5718 -0.6833 36.8878
LB996-RCC GDSC1; GDSC2 0.6331 3.9409 -0.0237 21.9034
KTCTL-195 GDSC1; GDSC2 0.9007 4.019 0.461 23.5256
BB65-RCC GDSC1 1.2001 4.0946 0.7574 24.2132
786-O GDSC1; GDSC2 1.9296 4.653 1.3086 15.4241
KMRC-20 GDSC1; GDSC2 2.2546 4.4722 1.7222 12.1219
LB1047-RCC GDSC1 2.3993 5.6263 1.3328 15.8877
OS-RC-2 GDSC1; GDSC2 2.4668 4.7597 1.8073 10.9515
RXF 393L GDSC1 2.5367 9.3342 -0.3613 24.5978
Caki-1 GDSC1 2.6499 9.1249 -0.157 23.26
SW156 GDSC1 2.7001 5.2085 1.8209 11.7453
ACHN GDSC1; GDSC2 2.7758 5.7689 1.6181 11.0209
CAL-54 GDSC1; GDSC2 2.9275 6.1773 1.5536 10.938
UO-31 GDSC1 3.0105 6.0302 1.7002 11.4583
LB2241-RCC GDSC1 3.0395 5.3409 2.0684 9.0029
KTCTL-13 GDSC1 3.1104 7.7033 0.9526 15.77
KTCTL-26A GDSC1 3.2255 12.5521 -1.3738 26.4337
SW13 GDSC1; GDSC2 3.2501 5.1769 2.334 5.7096
SN12C GDSC1; GDSC2 3.3245 4.9026 2.5338 4.399
A-498 GDSC1; GDSC2 3.4013 5.2711 2.4127 4.8828
BFTC-909 GDSC1; GDSC2 3.4783 7.7161 1.2538 11.1202
NCC010 GDSC1 3.5136 6.3493 1.9649 8.2334
KTCTL-21 GDSC1 3.9697 6.2664 2.3483 4.6215
VMRC-RCW GDSC1 4.0478 7.1545 1.9718 8.253
TK-10 GDSC1; GDSC2 4.0829 6.486 2.3204 3.9202
HA7-RCC GDSC1 4.1198 12.2185 -0.4802 20.2509
VMRC-RCZ GDSC1; GDSC2 4.3537 6.0293 2.7007 1.5532
769-P GDSC1; GDSC2 4.6005 12.8322 -0.4143 16.6843
A-704 GDSC1; GDSC2 4.7263 7.7763 2.1279 3.8126
KMRC-1 GDSC1; GDSC2 5.0294 8.8836 1.8026 4.9712
RCC10RGB GDSC1; GDSC2 5.1636 6.6682 2.8244 0.3986
BFTC-909 CTRP2 6.1245 7.1397 5.562 1.8783
TUHR10TKB CTRP2 6.4774 7.655 4.6547 0.2552
KMRC-20 CTRP2 7.1598 9.0256 5.3487 1.3473
NCC021 GDSC1 7.2226 16.2733 -0.2634 12.3512
OS-RC-2 CTRP2 7.4549 10.0306 5.0679 2.0504
A-498 CTRP2 7.8588 9.0585 5.6562 0.1288
TUHR4TKB CTRP2 7.9167 9.1637 5.6406 0.1371
KMRC-1 CTRP2 7.9937 9.2678 5.6325 0.1317
KMRC-2 CTRP2 8.0966 9.1989 5.6925 0.0554
SNU-1272 CTRP2 8.1625 14.1991 3.5684 6.9231
KMRC-3 CTRP2 8.2267 11.1716 4.9899 1.6002
ACHN CTRP2 8.2322 9.6455 5.5879 0.1405
UO-31 CTRP2 8.2857 14.937 3.2987 7.7968
RCC10RGB CTRP2 8.3041 9.7304 5.5845 0.1311
Caki-2 CTRP2 8.3612 9.3766 5.7225 0.0204
VMRC-RCW CTRP2 8.3792 9.9856 5.5228 0.1958
769-P CTRP2 8.6672 10.74 5.3617 0.3782
CAL-54 CTRP2 8.6762 10.5026 5.4509 0.2287
Caki-1 CTRP2 8.7123 10.4764 5.4735 0.1894
VMRC-RCZ CTRP2 8.888 10.3637 5.574 0.0644
786-O CTRP2 8.9984 10.4706 5.5759 0.054
⏷ Show the Full List of 53 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 92 Cell Line(s) in Large Intestine Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
SK-CO-1 GDSC1; GDSC2 0.2262 4.3549 -0.3859 30.1475
SNU-175 GDSC2 2.8054 6.5348 0.7906 10.1124
SW620 GDSC1; GDSC2 2.9426 5.1072 2.0963 7.891
C2BBe1 GDSC1; GDSC2 2.9672 4.2879 2.5188 5.4911
SW48 GDSC1; GDSC2 3.1112 5.8638 1.8713 8.6649
MDST8 GDSC1; GDSC2 3.1679 5.1742 2.2645 6.3186
SNU-C5 GDSC1; GDSC2 3.1839 5.3395 2.1959 6.6578
HCT 116 GDSC1; GDSC2 3.1972 5.8895 1.9328 8.09
HCT 15 GDSC1; GDSC2 3.2665 5.1775 2.3476 5.5905
SNU-1040 GDSC1 3.3581 5.0132 1.0279 0.8546
LS513 GDSC1; GDSC2 3.4494 5.9597 2.1077 6.467
LS180 GDSC1; GDSC2 3.5334 7.3376 1.4875 9.7042
HCC2998 GDSC1; GDSC2 3.5959 6.331 2.0392 6.4964
CW-2 GDSC1; GDSC2 3.5959 8.0895 1.1625 11.3228
RKO GDSC1; GDSC2 3.6026 5.5955 2.4097 4.4225
LS411N GDSC1; GDSC2 3.8734 5.7052 2.5527 3.0736
SNU-C2B GDSC1; GDSC2 3.8778 6.5686 2.1353 5.3345
HT115 GDSC1 3.9272 5.5724 2.6524 2.8335
SW626 GDSC1; GDSC2 3.9431 6.4322 2.2491 4.5776
KM12 GDSC1; GDSC2 3.9601 6.032 2.4548 3.4333
SW1417 GDSC1; GDSC2 4.0086 5.7701 2.6119 2.514
LoVo GDSC1; GDSC2 4.0343 7.7069 1.6911 7.4316
SNU-81 GDSC1 4.057 6.7592 2.1706 5.5336
GP5d GDSC1; GDSC2 4.1324 7.156 2.0311 5.3799
HT-29 GDSC1; GDSC2 4.1573 5.3717 2.881 0.9763
HT-55 GDSC1; GDSC2 4.1754 5.7836 2.7086 1.7589
SNU-407 GDSC1; GDSC2 4.1773 10.1299 0.6019 12.8759
DiFi GDSC1; GDSC2 4.1805 7.3137 1.9884 5.515
LS123 GDSC1; GDSC2 4.1956 6.6229 2.3305 3.6596
COLO205 GDSC1; GDSC2 4.2188 8.2858 1.542 7.8478
SW837 GDSC1; GDSC2 4.2634 6.5437 2.4118 3.1178
SNU-61 GDSC1; GDSC2 4.4276 6.1313 2.0123 0.6528
COLO 320HSR GDSC1; GDSC2 4.5323 8.6858 1.5694 7.0685
LS1034 GDSC1; GDSC2 4.7148 6.6823 2.6114 1.5195
CL-11 GDSC1; GDSC2 4.7983 8.7831 1.702 5.8788
SW1463 GDSC1; GDSC2 4.8043 7.0703 2.4913 1.9473
COLO 678 GDSC1; GDSC2 4.8072 6.4332 2.7609 0.8267
NCI-H716 GDSC1; GDSC2 4.833 11.4095 0.4578 12.1571
RCM-1 [Human ESC] GDSC1; GDSC2 5.0118 8.7012 1.8762 4.628
SW1116 GDSC1; GDSC2 5.1538 7.3682 2.5447 1.3436
NCI-H508 GDSC1 5.2891 11.5333 0.7174 11.3724
NCI-H747 GDSC1; GDSC2 5.4979 7.4728 2.6599 0.6778
CCK-81 GDSC1; GDSC2 5.5072 7.145 2.7856 0.343
T84 GDSC1; GDSC2 5.7969 8.6241 2.3393 1.5544
SNU-C1 GDSC1; GDSC2 6.0863 7.7445 2.7892 0.1694
CaR-1 GDSC1; GDSC2 6.1413 7.7567 2.8044 0.1392
T84 CTRP2 6.9958 9.8619 4.8585 3.4199
SW948 GDSC1; GDSC2 6.9973 18.1297 -1.2883 15.4402
SK-CO-1 CTRP2 7.0236 14.4931 2.6058 12.4663
SW1116 CTRP2 7.0631 8.4992 4.5766 0.2079
COLO205 CTRP2 7.0715 10.9457 4.388 5.2111
NCI-H508 CTRP2 7.1321 10.2117 4.7826 3.5351
HCC-56 CTRP2 7.1674 8.5315 5.5652 0.6275
HT-55 CTRP2 7.2538 9.6836 5.1066 2.1285
COLO201 CTRP2 7.3086 12.5625 3.7695 7.3632
OUMS-23 CTRP2 7.3334 8.891 5.4977 0.7104
HCT 15 CTRP2 7.4753 9.671 5.239 1.4259
LS1034 CTRP2 7.4793 9.1194 5.4743 0.6789
LS513 CTRP2 7.4834 9.5688 5.2877 1.255
LS411N CTRP2 7.5204 8.5503 5.7095 0.1312
GP2d CTRP2 7.5387 9.3349 5.4145 0.8119
LS123 CTRP2 7.5407 9.6698 5.2745 1.2491
CW-2 CTRP2 7.5687 9.5151 4.4051 0.3557
C2BBe1 CTRP2 7.5909 13.8555 3.3406 8.6477
HCT 8 CTRP2 7.6608 8.884 5.6435 0.1979
SNU-C4 CTRP2 7.6761 8.6697 5.7249 0.0805
HT115 CTRP2 7.698 9.0283 5.6053 0.2546
SW48 CTRP2 7.7195 11.5369 4.537 3.7382
RKO CTRP2 7.7627 13.1556 3.7988 6.5743
SNU-C5 CTRP2 7.7781 10.3362 5.113 1.5777
CL-11 CTRP2 7.8133 13.3972 3.7173 6.8255
SNU-407 CTRP2 7.8428 9.7848 5.3758 0.7234
SNU-1033 CTRP2 7.874 15.2247 2.8752 10.0328
SNU-C1 CTRP2 7.8921 11.183 4.8026 2.5502
MDST8 CTRP2 7.9536 9.4007 5.57 0.2353
KM12 CTRP2 8.2233 10.943 5.0843 1.3087
SW620 CTRP2 8.2297 9.6048 5.6011 0.1251
RCM-1 [Human ESC] CTRP2 8.2771 9.4277 5.6778 0.0487
SNU-61 CTRP2 8.2831 10.1262 5.4344 0.3746
COLO 320 CTRP2 8.314 11.5165 4.8881 1.8567
LS180 CTRP2 8.3461 9.5866 5.6483 0.0633
COLO 678 CTRP2 8.3502 10.1318 5.4591 0.3056
NCI-H716 CTRP2 8.3663 11.6359 4.8644 1.89
SW1417 CTRP2 8.3681 10.4285 5.3558 0.5034
SW948 CTRP2 8.3925 17.5401 2.1164 12.0667
SNU-503 CTRP2 8.5194 10.0314 5.558 0.124
CCK-81 CTRP2 8.6661 10.2983 5.5187 0.143
LoVo CTRP2 8.8021 10.909 5.3531 0.3502
SNU-C2A CTRP2 8.9595 10.9828 5.3869 0.2535
HCT 116 CTRP2 12.8281 34.2734 -2.8951 19.7016
DLD-1 CTRP2 13.0761 34.3066 -2.7432 19.1053
HT-29 CTRP2 13.4457 34.8424 -2.7517 18.7004
⏷ Show the Full List of 92 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 1 Cell Line(s) in Leukemia Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
MO-T GDSC1; GDSC2 4.0023 7.9858 1.5299 8.3789
Cancer Drug Sensitivity Data Curated from 35 Cell Line(s) in Liver Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
JHH-6 GDSC1; GDSC2 2.2382 5.7702 1.1086 15.4423
HLE GDSC1; GDSC2 2.6383 4.759 1.9766 9.4807
JHH-4 GDSC1; GDSC2 2.9727 4.5668 2.3889 6.1871
HuH-1 GDSC1; GDSC2 3.0111 5.9576 1.7369 9.6884
JHH-7 GDSC1; GDSC2 3.2018 6.0471 1.8579 8.4953
Hep 3B2.1-7 GDSC1 3.29 4.6462 2.633 4.5598
SNU-398 GDSC1; GDSC2 3.3288 4.7954 2.5909 4.0689
SNU-387 GDSC1; GDSC2 3.7003 5.9918 2.2877 4.8796
JHH-1 GDSC1; GDSC2 3.9797 5.4247 2.755 1.8253
JHH-2 GDSC1; GDSC2 4.2311 6.5341 2.3956 3.2565
SK-HEP-1 GDSC1; GDSC2 4.2629 7.1994 2.1002 4.7569
SNU-449 GDSC1; GDSC2 4.4265 6.6691 2.4548 2.6385
SNU-423 GDSC1; GDSC2 4.8355 10.0412 1.1248 8.8034
Hep-G2/C3A GDSC1; GDSC2 5.0185 7.9146 2.2379 2.8463
Huh-7 GDSC1; GDSC2 5.4824 12.8651 0.2088 12.0375
JHH-6 CTRP2 7.3209 8.2647 5.7358 0.1429
Hep-G2 CTRP2 7.3985 8.7165 5.5981 0.3975
SNU-398 CTRP2 7.4128 9.4483 4.367 0.4941
SK-HEP-1 CTRP2 7.5505 9.0625 5.5299 0.4869
JHH-1 CTRP2 7.8875 9.2211 5.6093 0.1896
HLF CTRP2 8.0629 9.5461 5.5597 0.2206
Hep 3B2.1-7 CTRP2 8.1799 9.5729 5.5941 0.143
SNU-387 CTRP2 8.2208 10.4774 5.2726 0.7763
HuH-1 CTRP2 8.2692 9.5578 5.6313 0.087
SNU-475 CTRP2 8.2717 9.5184 5.6455 0.0739
JHH-4 CTRP2 8.2764 10.1308 5.4299 0.3858
Li-7 CTRP2 8.3048 10.9764 5.1104 1.1731
PLC/PRF/5 CTRP2 8.3543 9.7786 5.586 0.1207
SNU-423 CTRP2 8.3976 9.8512 5.5765 0.1239
HuH-6 CTRP2 8.3988 10.4312 5.3677 0.4654
JHH-2 CTRP2 8.4087 9.8413 5.5838 0.1141
JHH-5 CTRP2 8.7051 10.2905 5.5353 0.1189
SNU-449 CTRP2 8.8853 10.5587 5.5074 0.1202
SNU-182 CTRP2 9.2087 10.8163 5.5324 0.0641
SNU-761 CTRP2 13.7594 37.8218 -3.9654 20.6792
⏷ Show the Full List of 35 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 321 Cell Line(s) in Lung Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
NCI-H209 GDSC1; GDSC2 -0.9203 5.4603 -2.0273 40.7745
NCI-H1975 CTRP2 -0.871 9.0238 -2.4838 47.322
LC-1F CTRP2 -0.5677 11.7592 -7.6847 30.0438
NCI-H1876 GDSC1; GDSC2 0.0731 3.1435 -0.1765 29.8997
NCI-H2023 GDSC1; GDSC2 0.8481 5.0585 0.0084 25.8719
COR-L311 GDSC2 1.303 4.5823 0.3872 17.119
NCI-H526 GDSC1; GDSC2 1.4215 3.7765 1.1081 18.325
ABC-1 GDSC1 1.5636 8.9212 -1.0506 31.0022
NCI-H1781 GDSC1; GDSC2 1.6154 4.7264 0.9506 18.3927
SBC-3 GDSC1; GDSC2 1.7859 5.8509 0.626 19.4557
COR-L32 GDSC1; GDSC2 1.8276 6.0066 0.2082 16.336
COR-L279 GDSC1; GDSC2 1.9048 4.3675 1.4029 15.0239
NCI-H1105 GDSC1 1.9321 4.4376 1.4024 17.2991
HCC366 GDSC1 1.9592 6.121 0.6711 21.4812
HCC44 GDSC1; GDSC2 1.9603 5.0987 1.144 16.1776
COR-L23 GDSC1; GDSC2 2.2955 5.9651 1.071 15.4594
HOP-92 GDSC1; GDSC2 2.3319 6.4327 0.8803 16.3554
HOP-62 GDSC1; GDSC2 2.3373 4.7474 1.6834 12.0449
NCI-H290 GDSC1 2.3466 5.5561 1.3155 16.1902
NCI-H460 GDSC1 2.4046 3.8532 2.1384 10.9249
NCI-H23 GDSC1; GDSC2 2.419 4.8823 1.7031 11.6679
NCI-H2810 GDSC1 2.4295 5.5579 1.3945 15.396
NCI-H1341 GDSC1; GDSC2 2.4364 4.8381 1.7408 11.4084
NCI-H1651 GDSC1; GDSC2 2.4782 6.0622 1.1978 14.2089
NCI-H1437 GDSC1 2.5056 5.1256 1.674 13.3771
NCI-H1155 GDSC1; GDSC2 2.5411 5.0026 1.7668 10.9286
NCI-H1963 GDSC1; GDSC2 2.5448 6.0186 1.2815 13.5525
SK-LU-1 GDSC1; GDSC2 2.5506 5.3381 1.6161 11.7164
NCI-H2369 GDSC1; GDSC2 2.6303 6.6751 1.039 14.6032
NCI-H2110 GDSC1 2.6586 5.1446 1.8122 11.9494
NCI-H1694 GDSC1; GDSC2 2.7091 4.6949 2.0758 8.717
NCI-H1734 GDSC1 2.7181 4.7843 2.042 12.5127
NCI-H2030 GDSC1 2.7183 5.7383 1.58 13.2031
NCI-H82 GDSC1; GDSC2 2.7208 8.3899 0.271 18.3022
COLO 668 GDSC1; GDSC2 2.7534 6.3164 1.328 12.6773
A-549 GDSC1; GDSC2 2.8118 5.0353 2.0102 8.7563
LC-2/ad GDSC1 2.867 6.2737 1.4517 13.5042
Lu-99A GDSC1; GDSC2 2.885 5.195 2.0003 8.5914
DMS 273 GDSC1; GDSC2 3.0262 7.44 1.0115 13.6198
NCI-H2228 GDSC1; GDSC2 3.0325 7.5045 0.9848 13.7459
BEN GDSC1 3.0482 6.0759 1.7107 11.2696
NCI-H513 GDSC1; GDSC2 3.0494 7.0546 1.2238 12.4087
NCI-H2804 GDSC1 3.0648 5.016 2.2521 7.7369
NCI-H1792 GDSC1; GDSC2 3.0741 5.7627 1.8893 8.6666
ChaGo-K-1 GDSC1 3.1024 5.5365 2.0267 9.0676
PC-14 GDSC1; GDSC2 3.117 5.0431 2.2851 6.3443
EPLC-272H GDSC1; GDSC2 3.1277 6.9696 1.3338 11.5949
Lu-134-A GDSC1 3.1452 5.6162 2.0244 8.9464
DMS 79 GDSC1 3.1685 5.2207 2.2418 7.469
NCI-H1355 GDSC1; GDSC2 3.1781 6.0112 1.8556 8.5713
LB647-SCLC GDSC1 3.1795 7.0789 0.8122 10.5521
NCI-H2122 GDSC1; GDSC2 3.1806 5.5641 2.081 7.3076
NCI-H2227 GDSC1 3.1906 6.0738 1.835 10.0239
NCI-H1048 GDSC1; GDSC2 3.1928 5.7134 2.017 7.6322
NCI-H2087 GDSC1; GDSC2 3.202 6.5587 1.6025 9.9145
NCI-H524 GDSC1; GDSC2 3.2298 7.7328 1.0393 12.9214
NCI-H510A GDSC1 3.2368 7.9609 0.9311 18.4972
NCI-H650 GDSC1; GDSC2 3.241 5.499 2.1653 6.6762
NCI-H1581 GDSC1; GDSC2 3.2621 5.5034 2.1809 6.5335
NCI-H1650 GDSC1; GDSC2 3.2815 4.401 2.7484 3.3114
NCI-H196 GDSC1; GDSC2 3.2869 5.1011 2.403 5.2275
NCI-H1793 GDSC1; GDSC2 3.291 4.3145 2.7996 3.0001
RERF-LC-MS GDSC1 3.3119 4.5864 2.6813 4.1808
NCI-H647 GDSC1 3.319 6.5748 1.6931 10.5417
NCI-H838 GDSC1 3.3293 4.9666 2.5058 5.2665
EMC-BAC-2 GDSC1; GDSC2 3.3358 7.7879 1.1005 12.3142
NCI-H2170 GDSC1; GDSC2 3.3519 6.8229 1.5964 9.5582
NCI-H661 GDSC1; GDSC2 3.3671 5.1481 2.4462 4.7808
LCLC-103H GDSC1; GDSC2 3.3865 4.4753 2.7981 2.7668
RERF-LC-KJ GDSC1; GDSC2 3.4164 5.1086 2.5061 4.3238
Lu-135 GDSC1; GDSC2 3.4226 6.9356 1.5983 9.368
NCI-H841 GDSC1; GDSC2 3.4887 5.9249 2.1567 6.0977
NCI-H187 GDSC1 3.4918 5.2476 2.4968 4.8622
NCI-H1666 GDSC1; GDSC2 3.5105 6.2239 2.025 6.7792
A-427 GDSC1 3.5403 5.0953 2.61 4.0029
HARA [Human squamous cell lung carcinoma] GDSC1; GDSC2 3.5441 6.1808 2.0732 6.4297
KNS-62 GDSC1; GDSC2 3.5917 7.2014 1.6021 8.9303
NCI-H720 GDSC1; GDSC2 3.6418 4.71 2.873 1.7975
COR-L95 GDSC1; GDSC2 3.6542 6.6436 1.9292 6.9705
NCI-H2795 GDSC1; GDSC2 3.6562 6.2728 2.115 5.9354
SBC-5 GDSC1; GDSC2 3.7073 6.1381 2.2206 5.2348
NCI-H2405 GDSC1; GDSC2 3.7115 6.198 2.1942 5.3716
HCC827 GDSC1; GDSC2 3.7281 7.1686 1.7257 7.9249
NCI-H1688 GDSC1; GDSC2 3.7359 5.2216 2.691 2.5951
IST-SL2 GDSC1; GDSC2 3.7626 5.6403 2.5063 3.5448
NCI-H1944 GDSC1; GDSC2 3.7713 7.8946 1.3984 9.6208
SBC-1 GDSC1 3.7756 5.9667 2.3559 5.0318
CPC-N GDSC1; GDSC2 3.7833 6.4814 2.1083 5.6871
NCI-H2066 GDSC1; GDSC2 3.7899 5.8275 2.4345 3.881
NCI-H1304 GDSC1 3.7969 7.5439 1.5925 9.8264
NCI-H211 GDSC1; GDSC2 3.8195 7.5022 1.6306 8.2384
NCI-H1623 GDSC1; GDSC2 3.8243 9.181 0.7998 12.6899
NCI-H146 GDSC1 3.8653 6.2782 1.6647 3.3091
DMS 114 GDSC1; GDSC2 3.8673 6.8485 1.99 6.1551
LOU-NH91 GDSC1; GDSC2 3.8687 6.1966 2.3109 4.3931
NCI-H345 GDSC1; GDSC2 3.8688 5.6009 2.5997 2.8304
NCI-H226 GDSC1; GDSC2 3.8696 5.7698 2.5189 3.2627
NCI-H520 GDSC1; GDSC2 3.9042 6.9675 1.9587 6.2475
LCLC-97TM1 GDSC1; GDSC2 3.9077 8.2715 1.3168 9.7477
LK-2 GDSC1; GDSC2 3.915 8.0535 1.4304 9.115
Ms-1 GDSC1; GDSC2 3.9306 7.0317 1.9467 6.2566
NCI-H810 GDSC1; GDSC2 3.932 6.0314 2.4357 3.5896
NCI-H3122 GDSC1; GDSC2 3.9789 5.9808 2.4921 3.1985
NCI-H1299 GDSC1; GDSC2 3.9868 10.374 0.3335 14.6559
NCI-H1869 GDSC1; GDSC2 4.0051 6.2107 2.3996 3.6432
NCI-H64 GDSC1; GDSC2 4.0244 5.732 1.9876 1.0735
EBC-1 GDSC1; GDSC2 4.0482 5.9665 2.5449 2.7947
HCC78 GDSC1; GDSC2 4.0527 7.667 1.7243 7.2112
EMC-BAC-1 GDSC1 4.0729 9.4199 0.874 13.43
SW1271 GDSC1; GDSC2 4.0766 5.9985 2.5482 2.7285
NCI-H2085 GDSC1; GDSC2 4.0855 6.2607 2.4298 3.3337
NCI-H2141 GDSC1; GDSC2 4.1141 9.9042 0.6654 12.6991
Calu-6 GDSC1; GDSC2 4.1352 6.7323 2.2377 4.2635
Lu-139 GDSC1; GDSC2 4.1402 7.7941 1.7257 7.0191
NCI-H358 GDSC1; GDSC2 4.1421 6.8055 2.2072 4.4135
NCI-H522 GDSC1; GDSC2 4.1637 11.0362 -0.4081 13.3951
NCI-H2081 GDSC1 4.1671 11.5765 -0.6701 16.6127
IST-SL1 GDSC1 4.1819 6.2675 2.4893 3.3085
LXF 289 GDSC1; GDSC2 4.1865 7.8863 1.714 6.9861
LC-1/sq GDSC1; GDSC2 4.2157 10.8418 0.2784 14.3861
NCI-H1755 GDSC1; GDSC2 4.2518 6.2457 2.5432 2.4656
SW1573 GDSC1; GDSC2 4.2636 6.9182 2.2351 4.0404
VMRC-LCD GDSC1; GDSC2 4.2784 6.608 2.3912 3.1989
IA-LM GDSC1; GDSC2 4.2933 8.1838 1.6453 7.1383
NCI-H3255 GDSC1 4.321 6.9665 2.2498 4.4743
NCI-H2342 GDSC1; GDSC2 4.3362 7.0414 2.2243 3.9677
NCI-H1092 GDSC1; GDSC2 4.3475 6.9626 2.2689 3.7153
SK-MES-1 GDSC1; GDSC2 4.4037 7.659 1.9751 5.1595
NCI-H1573 GDSC1; GDSC2 4.4272 5.8298 2.8253 0.9218
COR-L88 GDSC1; GDSC2 4.4771 6.4795 2.5702 2.0028
NCI-H1693 GDSC1; GDSC2 4.4817 8.0009 1.8641 5.6028
NCI-H1975 GDSC1; GDSC2 4.5036 8.3679 1.7029 6.4158
NCI-H2595 GDSC1; GDSC2 4.5079 8.1435 1.8135 5.822
NCI-H2722 GDSC1; GDSC2 4.5394 10.0243 0.9232 10.441
NCI-H1648 GDSC1; GDSC2 4.566 8.414 1.7232 6.1907
NCI-H446 GDSC1; GDSC2 4.5809 8.5126 1.686 6.3593
NCI-H2731 GDSC1; GDSC2 4.6047 8.5301 1.6937 6.2738
NCI-H2461 GDSC1; GDSC2 4.6253 9.4737 1.2529 8.553
NCI-H835 GDSC1; GDSC2 4.6306 7.4747 2.2084 3.558
NCI-H2172 GDSC1 4.6681 8.7991 1.6078 7.6297
NCI-H69 GDSC1; GDSC2 4.6908 7.6796 2.1508 3.7536
SHP-77 GDSC1; GDSC2 4.7084 8.3601 1.8434 5.3024
NCI-H2373 GDSC1; GDSC2 4.7188 7.5237 2.2395 3.2656
RERF-LC-Sq1 GDSC1; GDSC2 4.7273 10.4027 0.8734 10.3062
NCI-H2291 GDSC1 4.7849 7.1041 2.4659 2.4193
NCI-H1703 GDSC1; GDSC2 4.8075 7.3398 2.3743 2.485
NCI-H596 GDSC1; GDSC2 4.8149 7.2941 2.3988 2.36
COR-L105 GDSC1; GDSC2 4.8645 12.0629 0.1609 13.5104
NCI-H2444 GDSC1 4.8885 6.0746 2.9331 0.2964
NCI-H1563 GDSC1; GDSC2 4.9099 10.6843 0.8655 9.9785
NCI-H2818 GDSC1; GDSC2 4.9421 12.1506 0.1743 13.284
NCI-H1436 GDSC1 4.9495 6.7904 1.9797 0.5378
NCI-H1836 GDSC1 4.9941 6.7843 2.7065 1.0109
NCI-H727 GDSC1; GDSC2 5.0171 7.4249 2.4515 1.874
PaCa-3 GDSC1; GDSC2 5.0624 8.6896 1.9126 4.3668
NCI-H2029 GDSC1; GDSC2 5.0782 6.4596 2.8672 0.3309
Calu-3 GDSC1; GDSC2 5.0874 7.609 2.4094 1.9777
NCI-H441 GDSC1; GDSC2 5.1015 8.9978 1.7943 4.8967
Lu-65 GDSC1; GDSC2 5.1587 9.2039 1.7343 5.1069
DMS 53 GDSC1; GDSC2 5.1719 8.3379 2.1363 3.1196
NCI-H2347 GDSC1; GDSC2 5.1739 7.934 2.315 2.2942
NCI-H2135 GDSC1 5.181 6.6546 2.8364 0.4179
NCI-H322M GDSC1; GDSC2 5.2384 7.8357 2.3912 1.8888
NCI-H847 GDSC1; GDSC2 5.2482 7.0905 2.6996 0.7115
NCI-H292 GDSC1 5.2902 7.4906 2.56 1.3482
Lu-165 GDSC1; GDSC2 5.2947 9.1592 1.8374 4.3855
EKVX GDSC1 5.3917 7.7443 2.505 1.486
NCI-H2009 GDSC1; GDSC2 5.5013 12.3138 0.487 10.6941
UMC-11 GDSC1; GDSC2 5.5087 7.5242 2.6448 0.7167
NCI-H1838 GDSC1; GDSC2 5.5986 8.1995 2.418 1.4301
NCI-H2869 GDSC1 5.6099 12.984 0.2391 13.162
NCI-H1435 GDSC1; GDSC2 5.648 7.1074 2.8516 0.1747
COR-L321 GDSC1 5.6575 7.39 2.7552 0.4083
NCI-H2803 GDSC1 5.8144 7.9171 2.6239 0.701
NCI-H1993 GDSC1; GDSC2 5.8211 8.1582 2.5351 0.8588
HCC15 GDSC1; GDSC2 5.8222 11.3512 1.1504 6.9295
NCI-H2085 CTRP2 5.8411 9.9214 3.2338 6.6423
CAL-12T GDSC1 5.8818 8.0927 2.5857 0.7814
NCI-H1184 CTRP2 5.9089 13.1302 2.388 15.3971
NCI-H2591 GDSC1; GDSC2 5.9391 7.8713 2.6902 0.3875
NCI-H1915 GDSC1; GDSC2 6.0152 13.1824 0.415 10.1021
NCI-H1770 GDSC1 6.0406 7.4947 2.8578 0.1108
NCI-H1341 CTRP2 6.3364 7.682 5.4544 1.97
Calu-6 CTRP2 6.6427 9.8662 4.6063 4.9833
LOU-NH91 CTRP2 6.886 9.0768 4.2776 1.0422
NCI-H446 CTRP2 6.9117 9.2042 4.2375 1.1503
NCI-H1734 CTRP2 6.9334 10.7782 4.3713 5.4897
NCI-H2106 CTRP2 7.0532 10.9323 4.3816 5.2644
HCC1195 CTRP2 7.0866 9.1087 4.3578 0.6778
RERF-LC-A1 CTRP2 7.2174 9.4562 5.1885 1.8654
LK2 CTRP2 7.2259 8.0859 5.7636 0.1244
NCI-H1105 CTRP2 7.2467 9.1762 5.3306 1.3256
NCI-H2087 CTRP2 7.2582 10.3786 4.7861 3.3537
NCI-H522 CTRP2 7.2608 9.6603 5.1214 2.0655
NCI-H526 CTRP2 7.2617 9.395 5.2419 1.6241
RERF-LC-Ad1 CTRP2 7.2726 8.3395 5.6888 0.2481
DMS 273 CTRP2 7.3667 9.209 5.3808 1.0489
NCI-H810 CTRP2 7.3989 8.9013 5.5248 0.5887
LCLC-97TM1 CTRP2 7.4857 9.7403 5.2143 1.5007
NCI-H69 CTRP2 7.4864 10.5265 4.8606 2.7845
NCI-H889 CTRP2 7.5254 19.1006 -0.0386 16.6342
DMS 53 CTRP2 7.5497 12.8265 3.8111 6.8327
SW1573 CTRP2 7.5938 9.7164 4.3409 0.4757
LC-1/sq-SF CTRP2 7.629 9.0836 5.556 0.3853
Calu-3 CTRP2 7.6346 10.5368 4.9443 2.3087
NCI-H2291 CTRP2 7.6361 10.6378 4.8995 2.4706
NCI-H358 CTRP2 7.6916 16.416 2.1591 13.0182
NCI-H1155 CTRP2 7.7166 9.2461 5.5311 0.4018
HCC15 CTRP2 7.7322 9.9099 5.271 1.1048
NCI-H1650 CTRP2 7.7361 9.6558 4.419 0.2799
LCLC-103H CTRP2 7.7508 16.0614 2.377 12.1163
NCI-H2126 CTRP2 7.7531 9.1412 5.5857 0.2726
HCC1833 CTRP2 7.7605 9.8869 5.2947 1.0111
NCI-H2029 CTRP2 7.7721 9.3774 5.5044 0.4372
DMS 114 CTRP2 7.7955 10.6337 4.9925 1.9736
NCI-H1435 CTRP2 7.8113 10.4294 5.0904 1.6239
DV-90 CTRP2 7.8352 9.7894 5.3704 0.7425
SHP-77 CTRP2 7.8572 9.304 5.5673 0.271
NCI-H2141 CTRP2 7.8646 9.7669 5.393 0.6647
NCI-H1339 CTRP2 7.877 9.4946 5.5042 0.3909
LUDLU-1 CTRP2 7.8891 13.3994 3.7674 6.5212
NCI-H2081 CTRP2 7.8972 9.5963 5.474 0.449
VMRC-LCD CTRP2 7.9487 9.4525 5.5492 0.2738
HCC1438 CTRP2 7.9619 10.0919 5.3076 0.8368
Lu-99 CTRP2 7.9687 12.5063 4.2417 4.5649
NCI-H2122 CTRP2 7.9689 9.5536 5.5199 0.3222
NCI-H1568 CTRP2 7.9841 11.2694 4.8165 2.4065
SK-LU-1 CTRP2 7.9894 12.0013 4.4885 3.6012
NCI-H1092 CTRP2 7.9944 9.4382 5.5723 0.2195
COR-L88 CTRP2 8.0034 9.6243 5.5076 0.3338
HOP-62 CTRP2 8.0054 9.9174 5.3967 0.5791
NCI-H650 CTRP2 8.0268 9.7295 5.4778 0.3851
NCI-H647 CTRP2 8.0349 10.3945 5.219 1.0413
COR-L95 CTRP2 8.0408 9.5 5.5678 0.2137
NCI-H196 CTRP2 8.0418 9.287 5.6433 0.1096
NCI-H1869 CTRP2 8.0695 9.8306 5.4574 0.4106
HCC78 CTRP2 8.0971 9.8473 5.4625 0.3888
HCC2935 CTRP2 8.1273 10.1714 5.3513 0.6276
NCI-H2009 CTRP2 8.1288 9.7744 5.5024 0.2995
RERF-LC-Ad2 CTRP2 8.1345 9.4663 5.6147 0.1264
DMS 79 CTRP2 8.1429 9.7135 5.5302 0.2464
NCI-H1573 CTRP2 8.1623 9.7295 5.5319 0.2378
COR-L105 CTRP2 8.1822 10.4086 5.2824 0.7727
NCI-H727 CTRP2 8.1943 9.7134 5.5499 0.201
NCI-H23 CTRP2 8.1957 10.1188 5.401 0.479
NCI-H2286 CTRP2 8.2023 9.815 5.5165 0.2519
NCI-H1755 CTRP2 8.2119 9.8857 5.4945 0.2867
NCI-H1581 CTRP2 8.2131 9.9817 5.4597 0.3507
Sq-1 CTRP2 8.2133 9.509 5.6282 0.0981
HCC366 CTRP2 8.2177 9.9779 5.463 0.3428
ChaGo-K-1 CTRP2 8.2493 10.0031 5.4663 0.3255
NCI-H1355 CTRP2 8.2542 10.9845 5.0823 1.292
HCC95 CTRP2 8.2569 9.8198 5.5357 0.2067
COR-L51 CTRP2 8.2843 9.7885 5.557 0.1698
NCI-H1693 CTRP2 8.2855 10.0121 5.4774 0.2938
NCI-H838 CTRP2 8.2874 9.4196 5.6839 0.0439
NCI-H1299 CTRP2 8.3014 10.3568 5.355 0.5346
NCI-H520 CTRP2 8.3027 10.1378 5.438 0.3605
HCC1171 CTRP2 8.3145 9.9124 5.5245 0.209
NCI-H841 CTRP2 8.3314 10.6007 5.2736 0.7132
NCI-H146 CTRP2 8.3338 9.742 5.5912 0.1183
NCI-H661 CTRP2 8.3371 11.2928 4.055 0.7964
NCI-H2196 CTRP2 8.3431 9.7753 5.583 0.1259
NCI-H1703 CTRP2 8.3722 10.5276 5.3198 0.5823
NCI-H2023 CTRP2 8.3784 10.0734 5.4912 0.2436
NCI-H1915 CTRP2 8.3853 9.72 5.6169 0.0849
NCI-H441 CTRP2 8.394 10.1673 5.4633 0.2848
NCI-H1395 CTRP2 8.3993 14.6602 3.5055 6.8478
T3M-10 CTRP2 8.402 10.0272 5.5166 0.1993
NCI-H1563 CTRP2 8.4085 10.0169 5.5227 0.1893
HARA [Human squamous cell lung carcinoma] CTRP2 8.4204 10.2381 5.4479 0.3034
NCI-H1694 CTRP2 8.4353 10.0758 5.5118 0.1983
NCI-H2030 CTRP2 8.4453 9.9857 5.5471 0.1497
NCI-H1666 CTRP2 8.4517 10.4552 5.3804 0.4187
HCC2279 CTRP2 8.4655 10.3679 5.4182 0.3417
NCI-H292 CTRP2 8.4826 10.1017 5.5203 0.1763
NCI-H1623 CTRP2 8.4967 10.4882 5.3864 0.3906
NCI-H322 CTRP2 8.5034 10.01 5.5597 0.1248
KNS-62 CTRP2 8.505 9.6882 5.6683 0.037
COLO 668 CTRP2 8.517 10.2282 5.4885 0.2125
NCI-H2172 CTRP2 8.5508 10.3647 5.4526 0.258
LXF 289 CTRP2 8.5591 10.4122 5.4387 0.2779
COLO 699 CTRP2 8.5593 10.1268 5.5395 0.1379
EBC-1 CTRP2 8.5737 10.2177 5.5131 0.1669
NCI-H1792 CTRP2 8.6018 10.3087 5.4916 0.189
SK-MES-1 CTRP2 8.6173 10.4665 5.4415 0.2577
HCC827 CTRP2 8.6283 10.2262 5.53 0.1368
NCI-H1838 CTRP2 8.6295 10.34 5.4909 0.1841
HCC4006 CTRP2 8.6443 10.1653 5.5565 0.1066
NCI-H2170 CTRP2 8.6457 10.1644 5.5573 0.1056
NCI-H1373 CTRP2 8.6734 10.4643 5.4634 0.2116
NCI-H2342 CTRP2 8.6788 10.2545 5.5383 0.1198
DMS 454 CTRP2 8.728 11.5337 5.0835 0.9813
RERF-LC-MS CTRP2 8.7307 10.4022 5.5061 0.1462
NCI-H211 CTRP2 8.7476 10.1951 5.5823 0.0719
NCI-H1793 CTRP2 8.7656 10.6259 5.4407 0.2223
Lu-65 CTRP2 8.7695 10.4015 5.5201 0.1247
NCI-H1944 CTRP2 8.8124 10.6183 5.4606 0.1856
EPLC-272H CTRP2 8.8258 10.8979 5.3663 0.3207
NCI-H1651 CTRP2 8.845 10.8116 5.4046 0.2554
HCC2108 CTRP2 8.9933 10.6496 5.5144 0.0994
NCI-H1568 GDSC1; GDSC2 8.9936 17.6815 0.1362 7.009
EKVX CTRP2 9.0022 11.2064 5.3231 0.3415
NCI-H2405 CTRP2 9.0229 10.8195 5.467 0.1408
HCC44 CTRP2 9.2007 10.9628 5.4807 0.1034
SW1271 CTRP2 9.2456 22.0617 0.5215 16.0413
Calu-1 CTRP2 9.3665 19.2032 1.9852 11.1222
NCI-H2110 CTRP2 9.4482 11.6966 5.3169 0.2406
HOP-92 CTRP2 9.7503 19.0479 2.3108 9.4801
NCI-H2444 CTRP2 10.3939 44.8405 -9.8588 32.2424
HCC1588 CTRP2 10.6303 21.0703 1.9226 9.7088
PC-14 CTRP2 10.6565 26.6248 -0.7018 17.4452
SBC-5 CTRP2 10.7753 24.5318 0.3839 14.3167
NCI-H226 CTRP2 11.4027 31.6983 -2.6378 20.9234
BEN CTRP2 11.8087 32.1569 -2.576 20.2826
NCI-H2228 CTRP2 12.2093 37.6544 -4.9639 24.1486
CAL-12T CTRP2 12.5657 31.996 -1.9815 18.0827
NCI-H460 CTRP2 12.8649 26.167 0.9388 10.2428
A-549 CTRP2 14.9456 31.1775 -0.1078 11.0052
MOR/CPR CTRP2 15.5144 37.3091 -2.577 16.1432
Hs 888.Lu CTRP2 7.7401 10.424 5.0541 1.8128
⏷ Show the Full List of 321 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 1 Cell Line(s) in Lymphoma Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
CBTCi002-A GDSC1; GDSC2 4.6811 7.1014 2.4087 2.4937
Cancer Drug Sensitivity Data Curated from 3 Cell Line(s) in Thigh Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
H-STS CTRP2 6.1726 9.1415 4.6013 5.8226
P-STS CTRP2 6.9642 11.3615 4.108 6.5222
SYO-1 CTRP2 7.5997 9.7995 5.2498 1.2798
Cancer Drug Sensitivity Data Curated from 45 Cell Line(s) in Soft Tissue Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
Yamato-SS CTRP2 7.5646 8.7901 5.6398 0.2358
Aska-SS CTRP2 8.0737 19.3907 0.9777 16.4535
SW872 GDSC1; GDSC2 0.9382 3.409 0.6963 22.2448
VA-ES-BJ GDSC1; GDSC2 1.273 4.102 0.833 20.2592
EW-8 GDSC1; GDSC2 1.4055 3.1654 1.271 17.5998
G-402 GDSC1; GDSC2 1.5226 5.3148 0.6017 20.4966
Hs 633.T GDSC1; GDSC2 1.9968 4.743 1.339 15.0296
G-401 GDSC1; GDSC2 2.0618 5.36 1.1272 15.9221
KYM-1 GDSC1; GDSC2 2.1836 3.9721 1.8568 11.6771
MES-SA GDSC1; GDSC2 2.7399 5.7098 1.614 11.1499
SK-LMS-1 GDSC1; GDSC2 2.8937 5.8795 1.6708 10.3869
SW982 GDSC1; GDSC2 2.928 7.6998 0.7966 15.0337
MFH-ino GDSC1; GDSC2 2.9356 4.7198 2.2797 6.8995
HT-1080 GDSC1; GDSC2 2.9542 4.0424 2.6229 4.9665
GCT GDSC1; GDSC2 3.0228 8.0965 0.681 15.3739
RD GDSC1; GDSC2 3.2156 7.5999 1.0937 12.6661
A-204 GDSC1; GDSC2 3.2277 6.2617 1.7728 8.9008
RKN GDSC1; GDSC2 3.2368 3.9824 2.9183 2.4849
SK-UT-1 GDSC1; GDSC2 3.3042 6.4015 1.7674 8.7311
Rh41 GDSC1; GDSC2 3.3347 4.7417 2.6227 3.8762
Rh30 GDSC1; GDSC2 3.4292 6.9257 1.6087 9.2942
STS-0421 GDSC1 3.7185 8.1069 1.2514 12.1546
SW684 GDSC1; GDSC2 4.8845 6.0847 2.9279 0.2694
Rh18 GDSC1 4.9891 8.1782 2.1023 4.0994
RKN CTRP2 6.6852 9.1416 4.9918 3.3301
TE 441.T CTRP2 6.7731 9.4021 4.9272 3.4619
BT-12 CTRP2 6.8113 7.7202 5.7265 0.401
TTC-709 CTRP2 6.9397 11.9492 3.8008 7.8229
TE 617.T CTRP2 7.0922 9.6421 5.0258 2.6312
G-401 CTRP2 7.2875 10.4503 4.7713 3.3738
Rh41 CTRP2 7.3417 10.3918 4.8333 3.0637
SW982 CTRP2 7.5391 8.7835 5.632 0.2603
G-402 CTRP2 7.6257 10.8042 4.8175 2.7858
BT-16 CTRP2 7.6295 8.9207 5.6176 0.2553
A-204 CTRP2 7.6375 10.3068 5.0488 1.9311
KYM-1 CTRP2 7.757 9.9422 5.2699 1.0895
GCT CTRP2 7.8166 13.1517 3.8371 6.3472
RD CTRP2 7.9199 9.9139 5.3597 0.7207
MES-SA CTRP2 7.9847 9.1218 5.6796 0.0802
HT-1080 CTRP2 8.071 9.503 5.5783 0.1895
SK-UT-1 CTRP2 8.1752 9.7284 5.5373 0.2256
SK-LMS-1 CTRP2 8.1997 9.7337 5.5447 0.2075
Tm87-16 CTRP2 8.2597 10.085 5.4402 0.3717
Hs 729.T CTRP2 8.8937 10.2454 5.615 0.0397
Rh18 CTRP2 10.6978 22.0439 1.5105 10.9697
⏷ Show the Full List of 45 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 1 Cell Line(s) in Clivus Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
U-CH1 CTRP2 7.7937 9.5824 5.434 0.5982
Cancer Drug Sensitivity Data Curated from 69 Cell Line(s) in Ovary Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
2004 CTRP2 8.5986 15.4684 3.2532 7.5456
TOV-21G GDSC1; GDSC2 0.7434 7.0574 -0.97 30.3498
OV56 GDSC1; GDSC2 1.4003 3.4461 1.1896 18.0112
TYK-nu GDSC1; GDSC2 1.8443 4.7169 1.1928 16.3273
OAW42 GDSC1; GDSC2 1.9478 5.8004 0.8101 17.9638
OVTOKO GDSC1; GDSC2 2.13 5.6583 1.0559 16.0732
A2780 GDSC1; GDSC2 2.2104 4.8108 1.5267 13.3058
OC 314 GDSC1; GDSC2 2.3375 4.4341 1.824 11.2989
OVCAR-5 GDSC1; GDSC2 2.4571 5.7952 1.307 13.6851
TOV-112D GDSC1; GDSC2 2.6206 4.8524 1.9152 9.8704
ES-2 GDSC1; GDSC2 2.7607 5.4374 1.7665 10.2499
IGROV-1 GDSC1; GDSC2 2.7888 5.7117 1.6581 10.7621
OAW28 GDSC1; GDSC2 2.8081 6.5363 1.2687 12.8418
DOV13 GDSC1; GDSC2 2.9715 4.4883 2.426 5.9869
JHOS-4 GDSC1 3.0521 5.4304 2.0352 9.1753
OVK18 GDSC1 3.0647 9.5215 0.0053 21.093
OVISE GDSC1; GDSC2 3.1096 5.9363 1.8339 8.8775
EFO-27 GDSC1 3.3047 5.4106 2.2632 6.9116
SK-OV-3 GDSC1; GDSC2 3.6369 5.119 2.6704 2.9087
OVCAR-3 GDSC1; GDSC2 3.6376 7.2806 1.5991 8.8368
OVCAR-8 GDSC1; GDSC2 3.8211 8.3767 1.1975 10.5922
FU-OV-1 GDSC1; GDSC2 4.0052 6.1622 2.423 3.5183
Kuramochi GDSC1; GDSC2 4.1585 8.002 1.6372 7.46
JHOS-2 GDSC1 4.2953 8.943 1.2755 10.4931
OVKATE GDSC1; GDSC2 4.547 6.8144 2.4601 2.4345
OVCAR-4 GDSC1; GDSC2 5.0259 11.2442 0.6753 10.6979
OV-90 GDSC1; GDSC2 5.0841 9.7641 1.4245 6.8032
EFO-21 GDSC1; GDSC2 5.4229 7.1384 2.7547 0.4539
Caov-4 GDSC1; GDSC2 5.5038 13.6641 -0.163 13.6777
A2780 CTRP2 5.6073 7.5598 4.8974 5.7369
RMG-I GDSC1; GDSC2 5.8391 7.8562 2.6565 0.508
OVK18 CTRP2 6.721 9.4729 4.8561 3.8303
OV7 CTRP2 6.9457 9.5893 4.9551 3.1034
OVSAHO CTRP2 7.2735 11.2369 4.3873 4.9183
FU-OV-1 CTRP2 7.3861 19.9374 -0.552 18.4899
OV56 CTRP2 7.3997 8.6224 5.6348 0.3112
OAW42 CTRP2 7.4439 9.0377 5.4907 0.6555
JHOM-1 CTRP2 7.4539 8.8957 5.5524 0.4825
IGROV-1 CTRP2 7.5327 10.2644 5.0078 2.1862
HEY A8 CTRP2 7.5481 8.9481 5.5734 0.383
TOV-21G CTRP2 7.5847 8.8209 5.6365 0.235
SNU-119 CTRP2 7.6395 9.6893 5.317 1.0335
COV434 CTRP2 7.8524 10.1265 5.2405 1.108
JHOC-5 CTRP2 7.8891 9.5029 5.5061 0.3817
TYK-nu CTRP2 7.9096 9.6619 5.4541 0.4892
JHOS-2 CTRP2 7.9208 9.485 5.5259 0.3282
RMG-I CTRP2 7.9332 10.3414 5.191 1.1991
OC 314 CTRP2 7.9537 9.1974 5.6424 0.1271
OVCAR-5 CTRP2 7.9641 9.7344 5.4496 0.4739
OVCAR-4 CTRP2 7.9723 10.6482 5.0812 1.5154
DOV13 CTRP2 7.9744 9.5098 5.5383 0.2851
COV644 CTRP2 8.0371 9.4345 5.5898 0.1807
SNU-8 CTRP2 8.0535 14.305 3.4447 7.5562
COV362 CTRP2 8.1005 10.6478 5.1464 1.2108
OAW28 CTRP2 8.1966 10.5126 5.2475 0.857
MCAS CTRP2 8.2094 10.0645 5.4273 0.4172
OVCAR-8 CTRP2 8.2129 9.7579 5.5411 0.2097
TOV-112D CTRP2 8.3015 10.2778 5.3851 0.4684
EFO-21 CTRP2 8.3033 9.7801 5.567 0.1528
Caov-3 CTRP2 8.3296 9.9361 5.5217 0.2094
Kuramochi CTRP2 8.4358 10.2249 5.4587 0.2803
ES2 CTRP2 8.48 18.9227 1.5049 14.0663
SK-OV-3 CTRP2 8.5512 10.2163 5.5054 0.1814
OVTOKO CTRP2 8.6462 10.4618 5.4541 0.2313
OV-90 CTRP2 8.6844 10.0532 5.6081 0.0595
EFO-27 CTRP2 8.7208 10.4099 5.4998 0.1552
SNU-840 CTRP2 8.9885 10.6786 5.5029 0.1103
ONCO-DG-1 CTRP2 12.6698 27.4863 0.2133 12.5057
OVISE CTRP2 14.269 32.3813 -1.0641 14.0531
⏷ Show the Full List of 69 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 13 Cell Line(s) in Pleura Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
NCI-H28 GDSC1; GDSC2 3.3162 4.4415 2.7574 3.1706
MPP 89 GDSC1; GDSC2 3.5612 9.2894 0.5352 14.6981
MSTO-211H GDSC1; GDSC2 3.7468 6.6092 2.0176 6.2694
NCI-H2052 GDSC1; GDSC2 4.3804 9.5409 1.0444 10.1501
IST-Mes1 GDSC1; GDSC2 4.4255 8.7296 1.4735 7.7894
NCI-H2452 GDSC1; GDSC2 4.4688 6.9171 2.3665 3.0154
NCI-H2452 CTRP2 7.3589 16.0042 2.113 13.7447
NCI-H2052 CTRP2 7.3797 9.2336 4.4335 0.3668
ACC-MESO-1 CTRP2 7.5771 9.1154 5.521 0.4951
IST-Mes1 CTRP2 8.0006 11.7205 4.6234 3.0872
JL-1 CTRP2 8.1778 9.3869 5.6573 0.0751
MPP 89 CTRP2 8.2109 9.7007 5.5606 0.1814
NCI-H28 CTRP2 8.5903 10.1868 5.5299 0.1435
⏷ Show the Full List of 13 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 10 Cell Line(s) in Prostate Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
DU145 GDSC1; GDSC2 3.0914 5.3313 2.1192 7.339
PC-3 GDSC1; GDSC2 3.3806 5.3637 2.3495 5.2868
22Rv1 GDSC1; GDSC2 3.9468 7.7978 1.581 8.2232
LNCaP clone FGC GDSC1; GDSC2 5.3276 9.2238 1.8275 4.3852
VCaP GDSC1; GDSC2 5.5286 7.6022 2.6233 0.7701
VCaP CTRP2 7.9907 9.6633 5.4878 0.3788
PaCa-3 CTRP2 8.0613 9.0304 5.7364 0.0302
LNCaP clone FGC CTRP2 8.6787 10.4299 5.4775 0.1913
22Rv1 CTRP2 8.8681 10.8316 5.4062 0.2474
DU145 CTRP2 8.9106 10.8534 5.4144 0.2259
⏷ Show the Full List of 10 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 3 Cell Line(s) in Salivary Gland Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
A-253 GDSC1; GDSC2 2.298 4.1494 1.9055 11.0115
YD-15 CTRP2 7.4645 8.4965 5.7075 0.1486
A-253 CTRP2 8.6658 10.354 5.4993 0.1661
Cancer Drug Sensitivity Data Curated from 1 Cell Line(s) in Small Intestine Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
HuTu 80 GDSC1 3.1931 4.9794 2.3835 6.475
Cancer Drug Sensitivity Data Curated from 62 Cell Line(s) in Stomach Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
NUGC-3 GDSC1; GDSC2 -0.3312 3.1003 -0.6066 33.5356
SNU-5 GDSC1; GDSC2 1.9012 3.9694 1.5566 14.2528
HGC-27 GDSC1; GDSC2 2.8027 4.8599 2.0866 8.3644
MKN45 GDSC1; GDSC2 3.0214 5.144 2.1498 7.3666
SK-GT-2 GDSC1; GDSC2 3.0526 5.8095 1.8471 8.9607
RERF-GC-1B GDSC1; GDSC2 3.154 4.7694 2.4539 5.3009
SNU-1 GDSC1; GDSC2 3.2649 6.1237 1.8733 8.2431
TMK-1 GDSC1 3.2713 9.7854 0.0479 20.2268
AGS GDSC1; GDSC2 3.3936 7.6335 1.2256 11.4884
RF-48 GDSC1; GDSC2 3.4905 5.5996 2.3203 5.1808
SCH GDSC1 3.4965 6.6668 1.7927 9.3866
GCIY GDSC1; GDSC2 3.5845 5.9761 2.2069 5.5906
HSC-39 GDSC1; GDSC2 3.6814 5.5428 2.4949 3.778
TGBC11TKB GDSC1; GDSC2 3.7289 5.279 2.6583 2.7864
SNU-16 GDSC1; GDSC2 3.7918 8.3992 1.1635 10.8442
MKN7 GDSC1; GDSC2 3.8195 6.4694 2.1412 5.7233
KATO III GDSC1; GDSC2 3.9833 5.8622 2.5517 2.8745
MKN1 GDSC1; GDSC2 3.9978 8.7138 1.1665 10.3494
NUGC-4 GDSC1; GDSC2 4.1883 7.042 2.125 4.7658
ECC10 GDSC1; GDSC2 4.1952 7.2356 2.0364 5.2277
NCI-N87 GDSC1; GDSC2 4.5628 10.1791 0.8644 10.6932
MKN28 GDSC1; GDSC2 4.5794 8.1543 1.8563 5.4651
Hs 746.T GDSC1; GDSC2 4.6302 10.4039 0.8032 10.8635
Fu97 GDSC1; GDSC2 4.6392 9.3067 1.3435 8.0511
IM95 GDSC1; GDSC2 5.0207 6.8856 2.6781 0.9532
23132/87 GDSC1; GDSC2 5.5234 10.13 1.5307 5.5434
OCUM-1 GDSC1; GDSC2 5.9798 12.5734 0.6793 8.9267
GSU CTRP2 6.5624 7.6427 5.6246 0.9798
ECC10 CTRP2 6.7184 12.287 2.7054 7.4963
Fu97 CTRP2 7.2163 8.8406 4.5127 0.2724
Hs 746.T CTRP2 7.6515 10.0577 5.1659 1.5133
MKN7 CTRP2 7.7154 9.4373 5.4561 0.585
ECC12 CTRP2 7.7895 8.9995 5.6512 0.1511
MKN1 CTRP2 7.7943 9.3146 5.5377 0.3537
SNU-5 CTRP2 7.803 9.1543 5.6007 0.2283
HuG1-N CTRP2 7.8161 11.249 4.7283 2.9035
SNU-16 CTRP2 7.8427 9.0279 5.661 0.1259
NUGC-4 CTRP2 7.8597 9.8091 5.3739 0.7185
HGC-27 CTRP2 7.8624 10.5711 5.0563 1.6925
NCI-N87 CTRP2 7.9129 10.2102 5.2356 1.0785
SNU-620 CTRP2 7.9707 9.0006 5.7157 0.0508
23132/87 CTRP2 8.0052 9.5142 5.5489 0.256
SNU-668 CTRP2 8.0295 9.3295 5.6241 0.1352
GSS CTRP2 8.0538 9.6999 5.4999 0.3303
SNU-1 CTRP2 8.0742 9.847 5.4532 0.4177
NUGC-3 CTRP2 8.0834 9.7676 5.4867 0.3452
IM95 CTRP2 8.1477 9.9401 5.4486 0.3976
LMSU CTRP2 8.1812 11.0828 5.0042 1.5914
SNU-601 CTRP2 8.1872 9.6181 5.581 0.1586
AGS CTRP2 8.2643 17.6486 1.9722 12.779
SH-10-TC CTRP2 8.2816 9.3041 5.72 0.0252
KATO III CTRP2 8.309 10.2219 5.4093 0.415
SNU-216 CTRP2 8.5359 10.6916 5.3264 0.4964
NCC-StC-K140 CTRP2 8.73 11.3307 5.1643 0.776
MKN74 CTRP2 8.8953 11.0241 5.3476 0.3317
SNU-719 CTRP2 8.9066 10.5842 5.5062 0.1184
KE-39 CTRP2 9.9528 12.2859 5.2951 0.1761
MKN45 CTRP2 12.6172 30.4833 -1.2272 16.2807
SNG-M GDSC1; GDSC2 4.4037 6.652 2.4488 2.7034
SNG-M CTRP2 7.6386 13.5832 3.5067 7.9156
SNU-685 CTRP2 8.1946 9.3311 5.6818 0.0535
SNU-1077 CTRP2 8.4496 9.8373 5.5996 0.0924
⏷ Show the Full List of 62 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 28 Cell Line(s) in Thyroid Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
IHH-4 GDSC1; GDSC2 1.7 4.2213 1.245 16.582
CGTH-W-1 GDSC1; GDSC2 1.7711 4.3373 1.2743 16.1706
BHT-101 GDSC1; GDSC2 2.1358 5.1949 1.2769 14.8829
FTC-133 GDSC1; GDSC2 2.1755 6.0005 0.9385 16.5452
K5 GDSC1; GDSC2 2.5166 4.4921 1.9799 9.8624
HTC-C3 GDSC1; GDSC2 3.055 4.8121 2.3441 6.1919
ML-1 [Human leukemia] GDSC1 3.0597 11.3365 -0.9059 25.1781
KMH-2 GDSC1 3.1645 5.3728 2.1626 7.9936
CAL-62 GDSC1; GDSC2 3.2387 5.148 2.3386 5.7141
ASH-3 GDSC1; GDSC2 3.3735 6.2375 1.907 7.7762
WRO GDSC1; GDSC2 3.3836 4.3509 2.8579 2.4399
8505C GDSC1; GDSC2 3.7088 6.7563 1.9155 6.9203
TT2609-C02 GDSC1; GDSC2 3.8548 6.8799 1.9652 6.3191
TT GDSC1; GDSC2 4.1097 6.7023 2.2347 4.3277
8305C GDSC1; GDSC2 4.439 6.9554 2.3303 3.2461
B-CPAP GDSC1; GDSC2 5.3281 7.2426 2.6754 0.736
CGTH-W-1 CTRP2 7.8233 9.3925 5.5204 0.3787
SW579 CTRP2 7.9685 8.9888 5.7189 0.0487
TT CTRP2 8.0453 9.6748 5.5058 0.322
B-CPAP CTRP2 8.0541 9.3379 5.6301 0.1229
BHT-101 CTRP2 8.1498 9.8217 5.4934 0.309
CAL-62 CTRP2 8.1978 9.6282 5.5813 0.1559
FTC-133 CTRP2 8.26 9.5835 5.6193 0.1001
FTC-238 CTRP2 8.3158 9.3905 5.703 0.0312
8305C CTRP2 8.3664 12.7467 4.3736 3.6043
TT2609-C02 CTRP2 8.5935 10.7244 5.3378 0.4504
ML-1 [Human leukemia] CTRP2 10.4153 40.3157 -7.5989 29.8922
8505C CTRP2 12.7595 24.416 1.6674 8.1969
⏷ Show the Full List of 28 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 69 Cell Line(s) in Upper Aerodigestive Tract Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
HSC-4 GDSC1; GDSC2 0.8583 2.6724 0.7787 22.1885
PCI-06A GDSC1 0.9023 4.2472 0.3813 27.6254
KOSC-2 GDSC1 1.2388 5.3465 0.2954 26.5257
JHU-029 GDSC1 1.2893 5.5444 0.2615 26.4768
PCI-04B GDSC1 1.5495 4.5471 0.9556 21.5416
SKN-3 GDSC1; GDSC2 1.857 4.1078 1.4564 14.9256
JHU-011 GDSC1 1.8892 6.7862 0.2876 23.8407
HSC-3 GDSC1; GDSC2 2.0351 4.4756 1.4938 14.0869
SAS GDSC1; GDSC2 2.0492 4.8742 1.3346 14.8713
HSC-2 GDSC1; GDSC2 2.0593 6.527 0.5752 18.8056
CAL-27 GDSC1; GDSC2 2.5652 4.8233 1.8748 10.2666
BICR 22 GDSC1; GDSC2 2.5766 4.8339 1.881 10.1967
FaDu GDSC1; GDSC2 2.6199 4.8019 1.9384 9.7469
PCI-38 GDSC1 2.8764 5.042 2.0672 9.5598
BB30-HNC GDSC1 2.9095 7.2636 0.9976 16.1516
Ca9-22 GDSC1; GDSC2 2.9445 5.9739 1.6696 10.2487
BHY GDSC1 2.9944 4.5136 2.4351 6.8013
CAL-33 GDSC1; GDSC2 3.0548 5.9931 1.7577 9.4515
HO-1-N-1 GDSC1; GDSC2 3.0722 4.3797 2.5729 4.8756
KON GDSC1 3.1118 9.0226 0.2946 19.4614
BICR 78 GDSC1; GDSC2 3.1131 6.9056 1.3533 11.5277
PCI-30 GDSC1; GDSC2 3.1935 6.6173 1.566 10.1395
DOK GDSC1; GDSC2 3.2533 6.0706 1.89 8.1805
UPCI-SCC-090 GDSC1; GDSC2 3.3353 4.7145 2.6368 3.7956
NCI-H3118 GDSC1; GDSC2 3.3565 7.9806 1.0213 12.6861
HO-1-u-1 GDSC1; GDSC2 3.4269 4.5467 2.7947 2.6885
SAT [Human HNSCC] GDSC1; GDSC2 3.4325 8.8452 0.6519 14.4314
SCC-15 GDSC1; GDSC2 3.4926 7.1073 1.5695 9.3526
SCC-9 GDSC1; GDSC2 3.5349 5.3259 2.4915 4.1234
BICR 10 GDSC1; GDSC2 3.5866 6.851 1.7728 7.998
JHU-022 GDSC1; GDSC2 3.6205 8.1261 1.1639 11.2544
SCC-4 GDSC1; GDSC2 3.8018 7.2505 1.7419 7.667
Detroit 562 GDSC1; GDSC2 3.8371 5.9632 2.4021 3.9604
SCC-25 GDSC1 4.0147 6.782 2.1298 5.888
LB771-HNC GDSC1; GDSC2 4.2047 8.3543 1.4982 8.1134
BB49-HNC GDSC1; GDSC2 4.5832 9.6756 1.125 9.3052
OSC-20 GDSC1; GDSC2 4.6645 8.3216 1.8329 5.4348
PCI-15A GDSC1 5.4476 6.8974 2.8515 0.2651
OSC-19 GDSC1 5.8789 7.7211 2.7212 0.3985
YD-8 CTRP2 6.9089 10.4726 3.6817 3.185
SNU-1214 CTRP2 7.2703 10.4625 4.7544 3.4623
Detroit 562 CTRP2 7.3189 9.3104 5.3113 1.3238
PE/CA-PJ15 GDSC1 7.3706 16.717 -0.3773 12.5849
YD-10B CTRP2 7.5371 9.0686 5.5215 0.5158
HSC-4 CTRP2 7.5665 8.9966 5.5626 0.3994
CAL-27 CTRP2 7.8303 9.1175 5.6246 0.1809
BICR 22 CTRP2 7.8443 9.1144 5.631 0.1674
SNU-1066 CTRP2 7.8536 9.8506 5.3543 0.7754
HSC-2 CTRP2 7.8783 9.3306 5.5659 0.2665
HSC-3 CTRP2 8.0086 9.3271 5.6172 0.1486
FaDu CTRP2 8.0092 9.4719 5.5658 0.2259
BICR 56 CTRP2 8.0231 9.371 5.6071 0.1593
PE/CA-PJ41 (clone D2) CTRP2 8.0393 10.8409 5.0337 1.6136
BICR 31 CTRP2 8.0517 11.2745 4.8521 2.2152
PE/CA-PJ34 (clone C12) CTRP2 8.0525 9.3967 5.6089 0.1502
SCC-4 CTRP2 8.0778 10.4467 5.2183 1.0142
SNU-1076 CTRP2 8.1117 9.5928 5.5616 0.2044
SCC-25 CTRP2 8.116 10.0183 5.4056 0.5043
BICR 6 CTRP2 8.152 9.3018 5.677 0.0616
SNU-899 CTRP2 8.1602 9.625 5.5685 0.182
BICR 18 CTRP2 8.1637 9.9373 5.4562 0.3759
PE/CA-PJ49 CTRP2 8.2274 9.5466 5.6204 0.1041
CAL-33 CTRP2 8.2904 10.0973 5.448 0.3458
PE/CA-PJ15 CTRP2 8.3286 10.1419 5.4469 0.3348
SCC-9 CTRP2 8.5815 10.2397 5.5083 0.1714
SNU-46 CTRP2 8.5837 10.0025 5.5905 0.0835
BHY CTRP2 8.6563 10.5236 5.4359 0.2561
SNU-1041 CTRP2 8.7317 10.1426 5.5944 0.0646
BICR 16 CTRP2 12.2227 25.9858 0.6316 11.8333
⏷ Show the Full List of 69 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 40 Cell Line(s) in Urinary Tract Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
639V GDSC1; GDSC2 1.0737 2.7592 0.9959 20.2725
BFTC-905 GDSC1; GDSC2 1.3528 3.7079 1.0565 18.8475
647V GDSC1; GDSC2 1.4924 3.4291 1.2951 17.1321
T24 GDSC1 2.1472 6.1096 0.8591 19.6759
J82 GDSC1; GDSC2 2.2815 4.8461 1.5825 12.7698
5637 GDSC1; GDSC2 2.4203 5.1582 1.5754 12.3512
UM-UC-3 GDSC1; GDSC2 2.589 4.0682 2.2424 8.2244
TCCSUP GDSC1; GDSC2 2.7754 5.4177 1.7898 10.0776
CAL-29 GDSC1; GDSC2 2.9013 4.3758 2.4136 6.2713
KU-19-19 GDSC1; GDSC2 3.0988 5.6796 1.9523 8.2478
RT-112 GDSC1; GDSC2 3.3588 4.5087 2.759 3.0531
SW780 GDSC1; GDSC2 3.5496 6.4938 1.9215 7.2608
HT-1376 GDSC1; GDSC2 3.5727 5.1524 2.6064 3.4005
SW1710 GDSC1; GDSC2 3.8581 5.7873 2.5024 3.3742
RT-4 GDSC1; GDSC2 4.6382 12.918 -0.4282 16.66
HT-1197 GDSC1; GDSC2 4.7167 9.4594 1.3234 8.0047
253J CTRP2 6.1605 7.3651 5.4781 2.1654
BFTC-905 CTRP2 7.4913 9.0194 5.5202 0.5452
RT-4 CTRP2 7.494 10.8995 4.6923 3.4185
HT-1197 CTRP2 7.6554 9.3062 5.4808 0.5546
BC-3C CTRP2 7.7187 9.741 5.3347 0.9215
TCCSUP CTRP2 7.7456 9.3882 5.4887 0.4872
RT-112 CTRP2 7.7843 9.066 5.6255 0.1921
HT-1376 CTRP2 7.8084 10.7049 4.9682 2.0461
SCaBER CTRP2 7.8876 9.596 5.47 0.4627
639V CTRP2 7.9507 9.4625 5.5462 0.2785
VM-CUB-1 CTRP2 7.9509 10.2583 5.2343 1.0551
JMSU-1 CTRP2 8.1816 9.8244 5.505 0.2778
253J-BV CTRP2 8.2067 9.6428 5.5795 0.1564
J82 CTRP2 8.2116 9.9698 5.4635 0.3439
KMBC-2 CTRP2 8.2522 10.8767 5.126 1.1637
647V CTRP2 8.2727 9.5335 5.6408 0.0779
U-BLC1 CTRP2 8.2815 10.6582 5.2283 0.8578
SW1710 CTRP2 8.291 10.9274 5.1238 1.1434
UM-UC-3 CTRP2 8.4456 10.3285 5.4248 0.3363
CAL-29 CTRP2 8.542 9.8952 5.6122 0.0705
UM-UC-1 CTRP2 8.8117 10.8919 5.363 0.3304
5637 CTRP2 8.9842 10.6094 5.5248 0.0917
T24 CTRP2 9.756 16.4839 3.4973 5.2686
KU-19-19 CTRP2 12.545 30.1563 -1.1196 16.1061
⏷ Show the Full List of 40 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 40 Cell Line(s) in Urogenital System Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
NT2-D1 GDSC1; GDSC2 -0.1913 3.5205 -0.5681 32.7392
PA-1 GDSC1; GDSC2 0.8095 3.3373 0.5758 23.3424
SiSo GDSC1; GDSC2 1.2625 3.5984 0.9933 19.5123
NEC8 GDSC1; GDSC2 1.5925 3.9386 1.2364 17.0295
JAR GDSC1 2.1744 4.5516 1.6051 15.0847
ME-180 GDSC1; GDSC2 2.3092 4.454 1.7862 11.5958
TC-YIK GDSC1; GDSC2 2.4452 5.5548 1.4112 13.1587
C-33 A GDSC1; GDSC2 2.637 4.7033 2.0016 9.3498
Ca Ski GDSC1; GDSC2 2.6925 5.1109 1.8608 9.9405
JEG-3 GDSC1 2.7302 9.2029 -0.1251 22.834
PWR-1E GDSC1; GDSC2 2.8175 5.7854 1.6481 10.7333
HT-3 GDSC1; GDSC2 2.8838 4.8501 2.1678 7.6719
KGN GDSC1; GDSC2 2.9971 6.1657 1.621 10.3698
NCC-IT GDSC2 3.0381 4.8583 1.8002 3.5853
SW756 GDSC1; GDSC2 3.1188 4.5605 2.5262 4.9988
BPH-1 GDSC1; GDSC2 3.1264 6.6239 1.5053 10.655
SKN GDSC1; GDSC2 3.1824 6.0484 1.8407 8.6431
MS751 GDSC1; GDSC2 3.1924 4.5418 2.6009 4.3757
SW954 GDSC1 3.1925 6.3748 1.6864 10.97
CAL-39 GDSC1; GDSC2 3.2741 5.2295 2.328 5.6801
ACC-OV7 GDSC1 3.2744 6.1436 1.8713 9.5337
C-4-I GDSC1; GDSC2 3.3093 5.1764 2.3841 5.2749
HEC-1 GDSC1; GDSC2 3.3166 4.9175 2.5197 4.4981
OMC-1 [Human cervical carcinoma] GDSC1 3.3464 5.5193 2.2435 6.9146
HEY GDSC1; GDSC2 3.5075 5.3186 2.4737 4.2862
PEO1 GDSC1; GDSC2 3.5326 7.4026 1.4544 9.8884
SKG-IIIa GDSC1; GDSC2 3.5397 6.5365 1.8923 7.4471
SiHa GDSC1; GDSC2 3.5527 5.0332 2.6502 3.203
JHOS-3 GDSC1 3.8306 6.6027 2.0838 6.6265
SW962 GDSC1 3.8804 7.0584 1.8963 7.6914
DoTc2 4510 GDSC1; GDSC2 3.9718 7.4569 1.7679 7.1468
DSH1 GDSC1; GDSC2 4.1322 6.4726 2.3599 3.6185
OVCA420 GDSC1; GDSC2 4.2049 6.5524 2.37 3.4357
LB831-BLC GDSC1; GDSC2 4.2682 7.878 1.7762 6.4842
OVCA433 GDSC1 4.4215 8.487 1.5885 8.2978
OV17R GDSC1 4.5845 9.6359 1.1453 10.5651
UWB1.289 GDSC1 4.7802 9.8819 1.1634 10.0063
HeLa GDSC1; GDSC2 4.9898 11.8796 0.3409 12.3967
OVMIU GDSC1; GDSC2 5.1523 8.2211 2.1772 2.9534
HeLa CTRP2 7.3185 8.2685 5.7335 0.1474
⏷ Show the Full List of 40 Cancer Drug Sensitivity Data of This Drug

Drug-Drug Interaction (DDI) Information of This Drug

Coadministration of a Drug Treating the Disease Different from Cisplatin (Comorbidity)
DDI Drug Name DDI Drug ID Severity Mechanism Comorbidity REF
Remdesivir DMBFZ6L Moderate Decreased renal excretion of Cisplatin caused by Remdesivir mediated nephrotoxicity. 1D6YCoronavirus Disease 2019 [1D6YCoronavirus Disease 2019] [32]
Inotersen DMJ93CT Major Increased risk of nephrotoxicity by the combination of Cisplatin and Inotersen. Amyloidosis [5D00] [33]
Dronedarone DMA8FS5 Major Increased risk of ventricular arrhythmias by the combination of Cisplatin and Dronedarone. Angina pectoris [BA40] [34]
Roflumilast DMPGHY8 Moderate Additive immunosuppressive effects by the combination of Cisplatin and Roflumilast. Asthma [CA23] [33]
Ofloxacin DM0VQN3 Minor Decreased absorption of Cisplatin due to intestinal mucosa variation caused by Ofloxacin. Bacterial infection [1A00-1C4Z] [35]
Ciprofloxacin XR DM2NLS9 Minor Decreased absorption of Cisplatin due to intestinal mucosa variation caused by Ciprofloxacin XR. Bacterial infection [1A00-1C4Z] [35]
Trovafloxacin DM6AN32 Minor Decreased absorption of Cisplatin due to intestinal mucosa variation caused by Trovafloxacin. Bacterial infection [1A00-1C4Z] [35]
Sparfloxacin DMB4HCT Minor Decreased absorption of Cisplatin due to intestinal mucosa variation caused by Sparfloxacin. Bacterial infection [1A00-1C4Z] [35]
Gemifloxacin DMHT34O Minor Decreased absorption of Cisplatin due to intestinal mucosa variation caused by Gemifloxacin. Bacterial infection [1A00-1C4Z] [35]
Norfloxacin DMIZ6W2 Minor Decreased absorption of Cisplatin due to intestinal mucosa variation caused by Norfloxacin. Bacterial infection [1A00-1C4Z] [35]
ABT-492 DMJFD2I Minor Decreased absorption of Cisplatin due to intestinal mucosa variation caused by ABT-492. Bacterial infection [1A00-1C4Z] [35]
Rabeprazole DMMZXIW Moderate Increased risk of hypomagnesemia by the combination of Cisplatin and Rabeprazole. Bacterial infection [1A00-1C4Z] [36]
Levofloxacin DMS60RB Minor Decreased absorption of Cisplatin due to intestinal mucosa variation caused by Levofloxacin. Bacterial infection [1A00-1C4Z] [35]
Lomefloxacin DMVRH9C Minor Decreased absorption of Cisplatin due to intestinal mucosa variation caused by Lomefloxacin. Bacterial infection [1A00-1C4Z] [35]
Etidronic acid DM1XHYJ Moderate Increased risk of nephrotoxicity by the combination of Cisplatin and Etidronic acid. Bone paget disease [FB85] [37]
Iodipamide DMXIQYS Major Increased risk of nephrotoxicity by the combination of Cisplatin and Iodipamide. Cholelithiasis [DC11] [38]
Methoxyflurane DML0RAE Moderate Increased risk of nephrotoxicity by the combination of Cisplatin and Methoxyflurane. Corneal disease [9A76-9A78] [33]
Ethacrynic acid DM60QMR Moderate Increased risk of ototoxicity by the combination of Cisplatin and Ethacrynic acid. Essential hypertension [BA00] [39]
Amphotericin B DMTAJQE Moderate Increased risk of nephrotoxicity by the combination of Cisplatin and Amphotericin B. Fungal infection [1F29-1F2F] [32]
Dexlansoprazole DM1DBV5 Moderate Increased risk of hypomagnesemia by the combination of Cisplatin and Dexlansoprazole. Gastro-oesophageal reflux disease [DA22] [36]
Furosemide DMMQ8ZG Moderate Increased risk of ototoxicity by the combination of Cisplatin and Furosemide. Heart failure [BD10-BD1Z] [40]
Bumetanide DMRV7H0 Moderate Increased risk of ototoxicity by the combination of Cisplatin and Bumetanide. Heart failure [BD10-BD1Z] [40]
Brentuximab vedotin DMWLC57 Moderate Increased risk of peripheral neuropathy by the combination of Cisplatin and Brentuximab vedotin. Hodgkin lymphoma [2B30] [41]
Zalcitabine DMH7MUV Moderate Increased risk of peripheral neuropathy by the combination of Cisplatin and Zalcitabine. Human immunodeficiency virus disease [1C60-1C62] [42]
Teriflunomide DMQ2FKJ Major Additive immunosuppressive effects by the combination of Cisplatin and Teriflunomide. Hyper-lipoproteinaemia [5C80] [43]
Etelcalcetide DMHP9BL Major Increased risk of hypocalcemia by the combination of Cisplatin and Etelcalcetide. Hyper-parathyroidism [5A51] [33]
Diazoxide DML1538 Minor Increased risk of nephrotoxicity by the combination of Cisplatin and Diazoxide. Hypertension [BA00-BA04] [44]
Givosiran DM5PFIJ Moderate Increased risk of nephrotoxicity by the combination of Cisplatin and Givosiran. Inborn porphyrin/heme metabolism error [5C58] [32]
Balsalazide DM7I1T9 Moderate Increased risk of nephrotoxicity by the combination of Cisplatin and Balsalazide. Indeterminate colitis [DD72] [45]
Methotrexate DM2TEOL Moderate Increased risk of nephrotoxicity by the combination of Cisplatin and Methotrexate. Leukaemia [2A60-2B33] [32]
Ibandronate DM0QZBN Moderate Increased risk of nephrotoxicity by the combination of Cisplatin and Ibandronate. Low bone mass disorder [FB83] [46]
Denosumab DMNI0KO Moderate Additive immunosuppressive effects by the combination of Cisplatin and Denosumab. Low bone mass disorder [FB83] [47]
Arsenic trioxide DM61TA4 Major Increased risk of ventricular arrhythmias by the combination of Cisplatin and Arsenic trioxide. Mature B-cell lymphoma [2A85] [48]
Clofarabine DMCVJ86 Moderate Increased risk of nephrotoxicity by the combination of Cisplatin and Clofarabine. Mature B-cell lymphoma [2A85] [49]
Exjade DMHPRWG Major Increased risk of nephrotoxicity by the combination of Cisplatin and Exjade. Mineral absorption/transport disorder [5C64] [50]
Thalidomide DM70BU5 Major Additive thrombogenic effects by the combination of Cisplatin and Thalidomide. Multiple myeloma [2A83] [51]
Tecfidera DM2OVDT Moderate Additive immunosuppressive effects by the combination of Cisplatin and Tecfidera. Multiple sclerosis [8A40] [52]
Siponimod DM2R86O Major Additive immunosuppressive effects by the combination of Cisplatin and Siponimod. Multiple sclerosis [8A40] [32]
Fingolimod DM5JVAN Major Additive immunosuppressive effects by the combination of Cisplatin and Fingolimod. Multiple sclerosis [8A40] [53]
Ocrelizumab DMEZ2KH Moderate Additive immunosuppressive effects by the combination of Cisplatin and Ocrelizumab. Multiple sclerosis [8A40] [54]
Ozanimod DMT6AM2 Major Additive immunosuppressive effects by the combination of Cisplatin and Ozanimod. Multiple sclerosis [8A40] [33]
Omacetaxine mepesuccinate DMPU2WX Moderate Additive myelosuppressive effects by the combination of Cisplatin and Omacetaxine mepesuccinate. Myeloproliferative neoplasm [2A20] [55]
Levomethadyl Acetate DM06HG5 Major Increased risk of ventricular arrhythmias by the combination of Cisplatin and Levomethadyl Acetate. Opioid use disorder [6C43] [56]
Esomeprazole DM7BN0X Moderate Increased risk of hypomagnesemia by the combination of Cisplatin and Esomeprazole. Peptic ulcer [DA61] [36]
Pemetrexed DMMX2E6 Moderate Decreased renal excretion of Cisplatin caused by Pemetrexed mediated nephrotoxicity. Pleural mesothelioma [2C26] [57]
Fluphenazine DMIT8LX Moderate Increased risk of ventricular arrhythmias by the combination of Cisplatin and Fluphenazine. Psychotic disorder [6A20-6A25] [32]
Everolimus DM8X2EH Major Increased risk of nephrotoxicity by the combination of Cisplatin and Everolimus. Renal cell carcinoma [2C90] [58]
Temsirolimus DMS104F Major Increased risk of nephrotoxicity by the combination of Cisplatin and Temsirolimus. Renal cell carcinoma [2C90] [58]
Gatifloxacin DMSL679 Minor Decreased absorption of Cisplatin due to intestinal mucosa variation caused by Gatifloxacin. Respiratory infection [CA07-CA4Z] [35]
Canakinumab DM8HLO5 Moderate Additive immunosuppressive effects by the combination of Cisplatin and Canakinumab. Rheumatoid arthritis [FA20] [59]
Rilonacept DMGLUQS Moderate Additive immunosuppressive effects by the combination of Cisplatin and Rilonacept. Rheumatoid arthritis [FA20] [59]
Golimumab DMHZV7X Major Additive immunosuppressive effects by the combination of Cisplatin and Golimumab. Rheumatoid arthritis [FA20] [60]
Sulfasalazine DMICA9H Moderate Increased risk of nephrotoxicity by the combination of Cisplatin and Sulfasalazine. Rheumatoid arthritis [FA20] [45]
Leflunomide DMR8ONJ Major Additive myelosuppressive effects by the combination of Cisplatin and Leflunomide. Rheumatoid arthritis [FA20] [43]
Thioridazine DM35M8J Moderate Increased risk of ventricular arrhythmias by the combination of Cisplatin and Thioridazine. Schizophrenia [6A20] [32]
Paliperidone DM7NPJS Moderate Increased risk of ventricular arrhythmias by the combination of Cisplatin and Paliperidone. Schizophrenia [6A20] [32]
Trifluoperazine DMKBYWI Moderate Increased risk of ventricular arrhythmias by the combination of Cisplatin and Trifluoperazine. Schizophrenia [6A20] [32]
Risperidone DMN6DXL Moderate Increased risk of ventricular arrhythmias by the combination of Cisplatin and Risperidone. Schizophrenia [6A20] [32]
Amisulpride DMSJVAM Moderate Increased risk of ventricular arrhythmias by the combination of Cisplatin and Amisulpride. Schizophrenia [6A20] [32]
Pimozide DMW83TP Major Increased risk of ventricular arrhythmias by the combination of Cisplatin and Pimozide. Schizophrenia [6A20] [61]
Anthrax vaccine DM9GSWY Moderate Antagonize the effect of Cisplatin when combined with Anthrax vaccine. Sepsis [1G40-1G41] [62]
Sirolimus DMGW1ID Major Increased risk of nephrotoxicity by the combination of Cisplatin and Sirolimus. Transplant rejection [NE84] [58]
Azathioprine DMMZSXQ Moderate Additive immunosuppressive effects by the combination of Cisplatin and Azathioprine. Transplant rejection [NE84] [32]
Tacrolimus DMZ7XNQ Major Increased risk of nephrotoxicity by the combination of Cisplatin and Tacrolimus. Transplant rejection [NE84] [58]
Olsalazine DMZW9HA Moderate Increased risk of nephrotoxicity by the combination of Cisplatin and Olsalazine. Ulcerative colitis [DD71] [45]
Cinoxacin DM4EWNS Minor Decreased absorption of Cisplatin due to intestinal mucosa variation caused by Cinoxacin. Urinary tract infection [GC08] [35]
Nalidixic acid DMRM0JV Minor Decreased absorption of Cisplatin due to intestinal mucosa variation caused by Nalidixic acid. Urinary tract infection [GC08] [35]
Amiodarone DMUTEX3 Major Increased risk of ventricular arrhythmias by the combination of Cisplatin and Amiodarone. Ventricular tachyarrhythmia [BC71] [63]
Ganciclovir DM1MBYQ Moderate Increased risk of nephrotoxicity by the combination of Cisplatin and Ganciclovir. Virus infection [1A24-1D9Z] [32]
Valaciclovir DMHKS94 Moderate Increased risk of nephrotoxicity by the combination of Cisplatin and Valaciclovir. Virus infection [1A24-1D9Z] [33]
Valganciclovir DMS2IUH Moderate Additive myelosuppressive effects by the combination of Cisplatin and Valganciclovir. Virus infection [1A24-1D9Z] [32]
⏷ Show the Full List of 71 DDI Information of This Drug

Drug Inactive Ingredient(s) (DIG) and Formulation(s) of This Drug

DIG
DIG Name DIG ID PubChem CID Functional Classification
Mannitol E00103 6251 Diluent; Flavoring agent; Lyophilization aid; Plasticizing agent; Tonicity agent
Sodium chloride E00077 5234 Diluent; Tonicity agent
Pharmaceutical Formulation
Formulation Name Drug Dosage Dosage Form Route
Cisplatin 10mg/vial injectable 10mg/vial Injectable Injection
Jump to Detail Pharmaceutical Formulation Page of This Drug

References

1 Cisplatin FDA Label
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5343).
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
4 BDDCS applied to over 900 drugs
5 Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 1352 Drug Compounds
6 Estimating the safe starting dose in phase I clinical trials and no observed effect level based on QSAR modeling of the human maximum recommended daily dose
7 ADReCS-Target: target profiles for aiding drug safety research and application. Nucleic Acids Res. 2018 Jan 4;46(D1):D911-D917. doi: 10.1093/nar/gkx899.
8 Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan. Cancer Sci. 2013 Aug;104(8):1074-82. doi: 10.1111/cas.12186. Epub 2013 Jun 10.
9 Megalin genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin. Pharmacogenomics J. 2008 Feb;8(1):23-8. doi: 10.1038/sj.tpj.6500455. Epub 2007 Apr 24.
10 Cisplatin and DNA repair in cancer chemotherapy.Trends Biochem Sci.1995 Oct;20(10):435-9.
11 Overcoming platinum drug resistance with copper-lowering agents. Anticancer Res. 2013 Oct;33(10):4157-61.
12 Effect of cisplatin on the transport activity of PII-type ATPases. Metallomics. 2017 Jul 19;9(7):960-968.
13 Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6). Cancer Res. 2002 Nov 1;62(21):6172-7.
14 Copper transporter 2 regulates endocytosis and controls tumor growth and sensitivity to cisplatin in vivo. Mol Pharmacol. 2011 Jan;79(1):157-66.
15 Lentivirus-mediated RNAi silencing targeting ABCC2 increasing the sensitivity of a human nasopharyngeal carcinoma cell line against cisplatin. J Transl Med. 2008 Oct 4;6:55.
16 Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1-3 and multidrug and toxin extrusion family). J Pharmacol Exp Ther. 2006 Nov;319(2):879-86.
17 Hammerhead ribozyme against gamma-glutamylcysteine synthetase sensitizes human colonic cancer cells to cisplatin by down-regulating both the glutathione synthesis and the expression of multidrug resistance proteins. Cancer Gene Ther. 2001 Oct;8(10):803-14.
18 Inhibiting the function of ABCB1 and ABCG2 by the EGFR tyrosine kinase inhibitor AG1478. Biochem Pharmacol. 2009 Mar 1;77(5):781-93.
19 Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2. Am J Pathol. 2005 Dec;167(6):1477-84.
20 Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade. Cancer Lett. 2016 Jan 1;370(1):153-64.
21 Cytochrome P450 2E1 null mice provide novel protection against cisplatin-induced nephrotoxicity and apoptosis. Kidney Int. 2003 May;63(5):1687-96.
22 Role of glutathione S-transferase P1-1 in the cellular detoxification of cisplatin. Mol Cancer Ther. 2008 Oct;7(10):3247-55.
23 PharmGKB: A worldwide resource for pharmacogenomic information. Wiley Interdiscip Rev Syst Biol Med. 2018 Jul;10(4):e1417. (ID: PA150642262)
24 Glutathione S-transferase genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin. Anticancer Drugs. 2000 Sep;11(8):639-43.
25 Role of metallothionein in cisplatin sensitivity of germ-cell tumours. Int J Cancer. 2000 Mar 15;85(6):777-81.
26 Cisplatin reduces Brucella melitensis-infected cell number by inducing apoptosis, oxidant and pro-inflammatory cytokine production. Res Vet Sci. 2010 Apr;88(2):218-26.
27 GSTA4 mediates reduction of cisplatin ototoxicity in female mice. Nat Commun. 2019 Sep 12;10(1):4150.
28 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
29 Characterisation of cisplatin-induced transcriptomics responses in primary mouse hepatocytes, HepG2 cells and mouse embryonic stem cells shows conservation of regulating transcription factor networks. Mutagenesis. 2014 Jan;29(1):17-26.
30 Low doses of cisplatin induce gene alterations, cell cycle arrest, and apoptosis in human promyelocytic leukemia cells. Biomark Insights. 2016 Aug 24;11:113-21.
31 Acute hypersensitivity of pluripotent testicular cancer-derived embryonal carcinoma to low-dose 5-aza deoxycytidine is associated with global DNA Damage-associated p53 activation, anti-pluripotency and DNA demethylation. PLoS One. 2012;7(12):e53003. doi: 10.1371/journal.pone.0053003. Epub 2012 Dec 27.
32 Cerner Multum, Inc. "Australian Product Information.".
33 Cerner Multum, Inc. "UK Summary of Product Characteristics.".
34 Product Information. Multaq (dronedarone). sanofi-aventis , Bridgewater, NJ.
35 Johnson EJ, MacGowan AP, Potter MN, et al "Reduced absorption of oral ciprofloxacin after chemotherapy for haematological malignancy." J Antimicrob Chemother 25 (1990): 837-42. [PMID: 2373666]
36 FDA. U.S. Food and Drug Administration "FDA Drug Safety Communication: Low magnesium levels can be associated with long-term use of proton pump inhibitor drugs (PPIs).".
37 Chang JT, Green L, Beitz J "Renal failure with the use of zoledronic acid." N Engl J Med 349 (2003): 1676-9 discussion 1676-9. [PMID: 14573746]
38 Wong GT, Lee EY, Irwin MG. Contrast induced nephropathy in vascular surgery.?Br J Anaesth. 2016;117 Suppl 2:ii63-ii73. [PMID: 27566809]
39 Product Information. Edecrin (ethacrynic acid). Merck &amp Co, Inc, West Point, PA.
40 Komune S, Snow JB "Potentiating effects of cisplatin and ethacrynic acid in ototoxicity." Arch Otolaryngol 107 (1981): 594-7. [PMID: 7197152]
41 Carrion C, Espinosa E, Herrero A, Garcia B "Possible vincristine-isoniazid interaction." Ann Pharmacother 29 (1995): 201. [PMID: 7756727]
42 Argov Z, Mastaglia FL "Drug-induced peripheral neuropathies." Br Med J 1 (1979): 663-6. [PMID: 219931]
43 Product Information. Arava (leflunomide). Hoechst Marion-Roussel Inc, Kansas City, MO.
44 Markman M, Trump DL "Nephrotoxicity with cisplatin and antihypertensive medications." Ann Intern Med 96 (1982): 257. [PMID: 7199267]
45 Novis BH, Korzets Z, Chen P, Bernheim J "Nephrotic syndrome after treatment with 5-aminosalicylic acid." Br Med J (Clin Res Ed) 296 (1988): 1442. [PMID: 3132281]
46 Banerjee D, Asif A, Striker L, Preston RA, Bourgoignie JJ, Roth D "Short-term, high-dose pamidronate-induced acute tubular necrosis: The postulated mechanisms of bisphosphonate nephrotoxicity." Am J Kidney Dis 41 (2003): E18. [PMID: 12778436]
47 Product Information. Prolia (denosumab). Amgen USA, Thousand Oaks, CA.
48 Ohnishi K, Yoshida H, Shigeno K, et al. "Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia." Ann Intern Med 133 (2000): 881-5. [PMID: 11103058]
49 Product Information. Clolar (clofarabine). sanofi-aventis, Bridgewater, NJ.
50 Product Information. Exjade (deferasirox). Novartis Pharmaceuticals, East Hanover, NJ.
51 Bennett CL, Nebeker JR, Samore MH, et al "The Research on Adverse Drug Events and Reports (RADAR) project." JAMA 293 (2005): 2131-40. [PMID: 15870417]
52 Product Information. Vumerity (diroximel fumarate). Alkermes, Inc, Cambridge, MA.
53 Product Information. Gilenya (fingolimod). Novartis Pharmaceuticals, East Hanover, NJ.
54 Product Information. Ocrevus (ocrelizumab). Genentech, South San Francisco, CA.
55 Product Information. Synribo (omacetaxine). Teva Pharmaceuticals USA, North Wales, PA.
56 Cohen J "Long-term efficacy and safety of terazosin alone and in combination with other antihypertensive agents." Am Heart J 122 (1991): 919-25. [PMID: 1678923]
57 Product Information. Alimta (pemetrexed). Lilly, Eli and Company, Indianapolis, IN.
58 Product Information. Prograf (tacrolimus). Fujisawa, Deerfield, IL.
59 Product Information. Arcalyst (rilonacept). Regeneron Pharmaceuticals Inc, Tarrytown, NY.
60 Product Information. Cimzia (certolizumab). UCB Pharma Inc, Smyrna, GA.
61 Product Information. Orap Tablets (pimozide). Gate Pharmaceuticals, Sellersville, PA.
62 CDC. Centers for Disease Control and Prevention/ "Recommendations of the advisory committtee on immunization practices (ACIP): use of vaccines and immune globulins in persons with altered immunocompetence." MMWR Morb Mortal Wkly Rep 42(RR-04) (1993): 1-18. [PMID: 20300058]
63 Antonelli D, Atar S, Freedberg NA, Rosenfeld T "Torsade de pointes in patients on chronic amiodarone treatment: contributing factors and drug interactions." Isr Med Assoc J 7 (2005): 163-5. [PMID: 15792261]